{"content":"<li class=\"n-box-item date-title\" data-end=\"1548997199\" data-start=\"1548910800\" data-txt=\"Monday, December 23, 2019\">Thursday, January 31, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3428465\" data-ts=\"1548979131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTNP\" target=\"_blank\">TTNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428465-titan-pharmaplus-43-lauds-probuphine-relaunch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan Pharma +43% as it lauds Probuphine relaunch</a></h4><ul>   <li>Titan Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a>) is vaulting after hours, <font color=\"green\">up 43.1%</font>, after it notes <a href=\"https://seekingalpha.com/pr/17398657-titan-pharmaceuticals-reports-positive-initial-results-probuphine-relaunch\" target=\"_blank\">positive early results</a> from its relaunch of Probuphine (buprenorphine).</li>    <li>The company's seen a double-digit increase in total product shipments after assuming responsibility for Probuphine sales in mid-June. It's successfully completed the program's transition from Braeburn Pharmaceuticals, it says.</li>    <li>Preliminary information shows total shipments during the rest of that year rose sequentially by more than 20%, the company says.</li>    <li>Probuphine is the company's unique six-month treatment for Opioid Use Disorder.</li>    <li>More details are to come with Q4 and full-year results, due in late March.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428465\" data-linked=\"Titan Pharma +43% as it lauds Probuphine relaunch\" data-tweet=\"$TTNP - Titan Pharma +43% as it lauds Probuphine relaunch https://seekingalpha.com/news/3428465-titan-pharmaplus-43-lauds-probuphine-relaunch?source=tweet\" data-url=\"https://seekingalpha.com/news/3428465-titan-pharmaplus-43-lauds-probuphine-relaunch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428464\" data-ts=\"1548978254\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPTX\" target=\"_blank\">LPTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428464-leap-therapeuticsminus-16-on-planned-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leap Therapeutics -16% on planned offering</a></h4><ul>   <li>Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics'>LPTX</a>) has <font color=\"red\">tumbled 15.9%</font> after hours following the announcement of an <a href=\"https://seekingalpha.com/pr/17398514-leap-therapeutics-announces-proposed-public-offering-common-stock-warrants\" target=\"_blank\">offering of common stock and warrants</a>.</li>    <li>Those shares are said to come at $1.75 each, Bloomberg reports. The stock closed <font color=\"red\">down 10.4%</font> today to $1.95.</li>    <li>Raymond James and Ladenburg Thalmann are book-runners.</li>    <li>Net proceeds will go to general purposes, which may include funding new clinical trials of DKN-01 and TRX518.</li>    <li>Underwriters will get a 30-day greenshoe option to buy up to an additional 15% of shares and/or warrants.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428464\" data-linked=\"Leap Therapeutics -16% on planned offering\" data-tweet=\"$LPTX - Leap Therapeutics -16% on planned offering https://seekingalpha.com/news/3428464-leap-therapeuticsminus-16-on-planned-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3428464-leap-therapeuticsminus-16-on-planned-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428463\" data-ts=\"1548977832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EMN\" target=\"_blank\">EMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428463-eastman-chemicalminus-2-after-lackluster-q4-sees-slower-growth-in-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eastman Chemical -2% after lackluster Q4; sees slower growth in 2019</a></h4><ul><li>Eastman Chemical (NYSE:<a href='https://seekingalpha.com/symbol/EMN' title='Eastman Chemical Co.'>EMN</a>) <font color=\"red\">-2.3%</font> after-hours as it reports a sharp <a href=\"https://seekingalpha.com/news/3428408-eastman-chemical-misses-0_22-beats-revenue\" target=\"_blank\">Q4 earnings</a> miss and flat revenues, and guides FY 2019 earnings with the midpoint below consensus.</li><li>EMN says Q4 was \"challenging... primarily due to reduced demand for specialty products in China as well as the slow flow through of higher raw material costs in an environment of customer destocking beyond normal seasonality.\"</li><li>For FY 2019, the company forecasts EPS of $8.69-$9.02 (up 6%-10%) vs. $9.01 analyst consensus estimate.</li><li>EMN sees slower economic growth in 2019, with some of Q4's challenges persisting in the current quarter, but expects to benefit \"from the flow through of lower raw material costs, aggressive cost management and returning cash to stockholders through continued significant share repurchases.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3428463\" data-linked=\"Eastman Chemical -2% after lackluster Q4; sees slower growth in 2019\" data-tweet=\"$EMN - Eastman Chemical -2% after lackluster Q4; sees slower growth in 2019 https://seekingalpha.com/news/3428463-eastman-chemicalminus-2-after-lackluster-q4-sees-slower-growth-in-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3428463-eastman-chemicalminus-2-after-lackluster-q4-sees-slower-growth-in-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428461\" data-ts=\"1548976972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRX\" target=\"_blank\">BRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428461-brixmorplus-5_1-on-move-midcap-400\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brixmor +5.1% on move into MidCap 400</a></h4><ul>   <li>Brixmor Property Group (NYSE:<a href='https://seekingalpha.com/symbol/BRX' title='Brixmor Property Group Inc.'>BRX</a>) is <font color=\"green\">up 5.1%</font> in the wake of news that it's <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/864758_vectren4.pdf?force_download=true\" target=\"_blank\">joining the S&amp;P MidCap 400</a>.</li>    <li>It will replace Vectren (NYSE:<a href='https://seekingalpha.com/symbol/VVC' title='Vectren Corp'>VVC</a>), which is set to be acquired by S&amp;P 500 constituent CenterPoint Energy.</li>    <li>The moves are effective prior to next Wednesday's market open.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428461\" data-linked=\"Brixmor +5.1% on move into MidCap 400\" data-tweet=\"$BRX $BRX $VVC - Brixmor +5.1% on move into MidCap 400 https://seekingalpha.com/news/3428461-brixmorplus-5_1-on-move-midcap-400?source=tweet\" data-url=\"https://seekingalpha.com/news/3428461-brixmorplus-5_1-on-move-midcap-400\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428459\" data-ts=\"1548976784\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428459-amazon-turns-lower-cfo-tackles-margin-india-on-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon turns lower as CFO tackles margin, India on call</a></h4><ul>   <li>Amazon.com (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>), <font color=\"green\">up as much as 3.4%</font> in postmarket trading after its <a href=\"https://seekingalpha.com/news/3428376-amazon-reports-holiday-beats-aws-plus-46-percent\" target=\"_blank\">earnings report</a>, has given up gains and then some, dropping to a current <font color=\"red\">4.6% decline</font> as its conference call went on.</li>    <li>The call came in the backdrop of a holiday report that topped expectations but sported some soft revenue guidance in what some see as harbinger of an upcoming economic slowdown.</li>    <li>A number of questions on the call centered on slowing gross margin expansion. Gross margins were up 180 basis points Y/Y, CFO Brian Olsavsky noted, and \"while that's not up as much as the prior quarter, the positive tailwind still remains ... AWS 46% on an F/X-neutral basis, third-party continues to grow, advertising continues to grow.\"</li>    <li>The slowdown was \"mostly due to higher Amazon Fulfilled units and greater use of Amazon logistics\" -- in other words, higher shipping costs.</li>    <li>Olsavsky had little he could say about India: \"We're still evaluating the situation in India ... We feel very good about the long-term prospects, and doing a good job for Indian customers and Indian sellers.\"</li>    <li>On physical stores' 3% revenue decrease, he notes that's primarily Whole Foods, but it includes the bookstores, Amazon Go, and Four-Star. There were overlapping periods with the WF acquisition last year, and the company adjusted the calendar to align WF with Amazon, which added revenue days to last year's Q4. Adjusting for that, he notes that Whole Foods saw 6% growth.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428459\" data-linked=\"Amazon turns lower as CFO tackles margin, India on call\" data-tweet=\"$AMZN - Amazon turns lower as CFO tackles margin, India on call https://seekingalpha.com/news/3428459-amazon-turns-lower-cfo-tackles-margin-india-on-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3428459-amazon-turns-lower-cfo-tackles-margin-india-on-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>200&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428454\" data-ts=\"1548975079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POST\" target=\"_blank\">POST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428454-post-gains-after-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post gains after earnings beat</a></h4><ul><li>Post Holdings (NYSE:<a href='https://seekingalpha.com/symbol/POST' title='Post Holdings, Inc.'>POST</a>) is <font color=\"green\">up 1.3%</font> AH after the food company slides past Q4 estimates on sales growth of -1.5%. On a pro forma basis, sales were up 3.1% during the quarter.</li><li>Adjusted EBITDA increased 3.9% to $292.5M.</li><li>Looking ahead, Post expects to generate  adjusted EBITDA of $1.20B to $1.24B in 2019 vs. prior guidancee for $1.19B to $1.24B.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428434-post-holdings-beats-0_14-beats-revenue\" target=\"_blank\">Post Holdings beats by $0.14, beats on revenue</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428454\" data-linked=\"Post gains after earnings beat\" data-tweet=\"$POST - Post gains after earnings beat https://seekingalpha.com/news/3428454-post-gains-after-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3428454-post-gains-after-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428453\" data-ts=\"1548974799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTEX\" target=\"_blank\">OTEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428453-symc-abc-ci-and-deck-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SYMC, ABC, CI and DECK among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/OTEX' title='Open Text Corporation'>OTEX</a> <font color=\"green\">+8%</font>. <a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a> <font color=\"green\">+5.9%</font>. <a href='https://seekingalpha.com/symbol/DGII' title='Digi International Inc.'>DGII</a> <font color=\"green\">+5.5%</font>. <a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a> <font color=\"green\">+5.1%</font>. <a href='https://seekingalpha.com/symbol/SIGA' title='SIGA Technologies Inc.'>SIGA</a> <font color=\"green\">+4.7%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/KLIC' title='Kulicke and Soffa Industries, Inc.'>KLIC</a> <font color=\"red\">-7.7%</font>. <a href='https://seekingalpha.com/symbol/EPAY' title='Bottomline Technologies, Inc.'>EPAY</a> <font color=\"red\">-6.3%</font>. <a href='https://seekingalpha.com/symbol/FBHS' title='Fortune Brands Home & Security, Inc.'>FBHS</a> <font color=\"red\">-3.9%</font>. <a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a> <font color=\"red\">-3.3%</font>. <a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color=\"red\">-3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428453\" data-linked=\"SYMC, ABC, CI and DECK among notable after hour movers\" data-tweet=\"$OTEX $OTEX $NLOK - SYMC, ABC, CI and DECK among notable after hour movers https://seekingalpha.com/news/3428453-symc-abc-ci-and-deck-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3428453-symc-abc-ci-and-deck-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428445\" data-ts=\"1548973499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVS\" target=\"_blank\">CVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428445-health-care-names-lower-administration-proposes-rule-to-cut-drug-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health care names lower as administration proposes rule to cut drug prices</a></h4><ul><li>Shares of <a href=\"https://www.cnbc.com/2019/01/31/cvs-cigna-fall-after-trump-administration-proposes-rule-to-lower-drug-prices.html\" target=\"_blank\">health care stocks slip</a> after-hours following the Trump administration's announcement that it plans to target \"backdoor rebates\" as it seeks to lower drug costs for consumers.</li><li>The proposal from the U.S. Department of Health and Human Services would <a href=\"https://www.wsj.com/articles/u-s-proposes-curbing-drug-rebates-in-some-medicare-medicaid-plans-11548971322\" target=\"_blank\">limit rebates</a> worked out between drug companies and third parties that handle Medicare Part D as well as some Medicaid delivery systems; instead, the plan would encourage discounts to be given directly to patients.</li><li>\"This proposal has the potential to be the most significant change in how Americans\u2019 drugs are priced at the pharmacy counter, ever, and finally ease the burden of the sticker shock that millions of Americans experience every month for the drugs they need,\" HHS Secretary Azar says.</li><li>In after-hours trade: <a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a> <font color=\"red\">-2.3%</font>, <a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color=\"red\">-2.9%</font>, <a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health Inc.'>CAH</a> <font color=\"red\">-2.9%</font>, <a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a> <font color=\"red\">-1.3%</font>, <a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a> <font color=\"red\">-1.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428445\" data-linked=\"Health care names lower as administration proposes rule to cut drug prices\" data-tweet=\"$CVS $CVS $CI - Health care names lower as administration proposes rule to cut drug prices https://seekingalpha.com/news/3428445-health-care-names-lower-administration-proposes-rule-to-cut-drug-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3428445-health-care-names-lower-administration-proposes-rule-to-cut-drug-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428444\" data-ts=\"1548973348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENVA\" target=\"_blank\">ENVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428444-enovaplus-2_2-after-q4-revenue-beat-issues-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enova +2.2% after Q4 revenue beat, issues guidance</a></h4><ul><li>Enova International (NYSE:<a href='https://seekingalpha.com/symbol/ENVA' title='Enova International, Inc.'>ENVA</a>) <font color=\"green\">rises 2.2%</font> in after-hours trading after<a href=\"https://seekingalpha.com/pr/17398461-enova-reports-fourth-quarter-full-year-2018-results\" target=\"_blank\"> Q4 adjusted EPS</a> of 52 cents matches consensus estimate.</li><li>Q4 total revenue of $313M, exceeding consensus of $301.3M, increased 28% from $244M in the year-ago period.</li><li>Sees Q1 adjusted EPS of 85 cents-$1.06; consensus of $1.04; Q1 revenue of $280M-$300m; estimate of $293.1M.</li><li>Sees FY2019 adjusted EPS of $2.76-$3.40; analysts' estimate of $3.13; revenue of $1.25B-$1.31B compares with analysts' estimate of $1.26B.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428379-enova-eps-line-beats-revenue\" target=\"_blank\">Enova EPS in-line, beats on revenue</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428444\" data-linked=\"Enova +2.2% after Q4 revenue beat, issues guidance\" data-tweet=\"$ENVA - Enova +2.2% after Q4 revenue beat, issues guidance https://seekingalpha.com/news/3428444-enovaplus-2_2-after-q4-revenue-beat-issues-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3428444-enovaplus-2_2-after-q4-revenue-beat-issues-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428440\" data-ts=\"1548972553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTEX\" target=\"_blank\">OTEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428440-open-textplus-5-on-q2-beats-ediscovery-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Open Text +5% on Q2 beats, eDiscovery acquisition</a></h4><ul><li>Open Text (NASDAQ:<a href='https://seekingalpha.com/symbol/OTEX' title='Open Text Corporation'>OTEX</a>) <font color=\"green\">gains 5.4%</font> after Q2 beats with revenue relatively flat Y/Y.</li><li>Revenue breakdown: Cloud services and subscriptions, $219.2M (+5% Y/Y); Customer support, $310.4M (+1%); License, $132.8M (-2.5% Y/Y); Professional service and other, $72.9M (-10%).</li><li>The company also <a href=\"https://seekingalpha.com/pr/17398381-opentext-buys-catalyst-repository-systems-inc\" target=\"_blank\">announced</a> acquiring Catalyst Repository Systems, an eDiscovery solutions provider for corporate legal departments and law firms. The purchase price is approximately $75M in an all-cash transaction.</li><li><a href=\"https://seekingalpha.com/pr/17398374-opentext-reports-second-quarter-fiscal-year-2019-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428320-open-text-beats-0_08-beats-revenue\" target=\"_blank\">Open Text beats by $0.08, beats on revenue</a> (Jan. 31)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428343-open-text-declares-0_1518-dividend\" target=\"_blank\">Open Text declares $0.1518 dividend</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428440\" data-linked=\"Open Text +5% on Q2 beats, eDiscovery acquisition\" data-tweet=\"$OTEX - Open Text +5% on Q2 beats, eDiscovery acquisition https://seekingalpha.com/news/3428440-open-textplus-5-on-q2-beats-ediscovery-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3428440-open-textplus-5-on-q2-beats-ediscovery-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428426\" data-ts=\"1548971900\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFPT\" target=\"_blank\">PFPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428426-proofpointplus-1-on-q4-beats-in-line-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proofpoint +1% on Q4 beats, in-line guide</a></h4><ul><li>Proofpoint (NASDAQ:<a href='https://seekingalpha.com/symbol/PFPT' title='Proofpoint, Inc.'>PFPT</a>) <font color=\"green\">gains 1.1%</font> on Q4 beats with revenue up 35% Y/Y. In-line Q1 guidance has revenue of $198M to $200M (consensus: $197.81M) and EPS of $0.31 to $0.35 (consensus: $0.31).</li><li>In-line FY19 guidance has revenue from $870M to $874M (consensus: $876.51M) and EPS from $1.60 to $1.67 (consensus: $1.64).</li><li>Q4 billings totaled $269.9M, up 43% Y/Y.</li><li>Cash flow from operations totaled $55.1M and the company ended the quarter with $231.7M in cash and equivalents. FCF was $48.6M compared to last year's $30.3M.</li><li><a href=\"https://seekingalpha.com/pr/17398409-proofpoint-announces-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428327-proofpoint-beats-0_16-beats-revenue\" target=\"_blank\">Proofpoint beats by $0.16, beats on revenue</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428426\" data-linked=\"Proofpoint +1% on Q4 beats, in-line guide\" data-tweet=\"$PFPT - Proofpoint +1% on Q4 beats, in-line guide https://seekingalpha.com/news/3428426-proofpointplus-1-on-q4-beats-in-line-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3428426-proofpointplus-1-on-q4-beats-in-line-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428424\" data-ts=\"1548971594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORT\" target=\"_blank\">CORT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428424-corcept-sees-q4-revenue-below-consensus-shares-down-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corcept sees Q4 revenue below consensus; shares down 3% after hours</a></h4><ul><li>On a preliminary basis, Corcept Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CORT' title='Corcept Therapeutics Incorporated'>CORT</a>) <a href=\"https://seekingalpha.com/pr/17398387-corcept-therapeutics-announces-fourth-quarter-full-year-2018-preliminary-selected-financial\" target=\"_blank\">expects </a>a 25% jump in Q4 revenue to $66.8M, below consensus of $70.4M.</li><li>2018 revenue will be up 58% to $251.2M, also shy of consensus of $254.8M.</li><li><strong>2019 guidance</strong>: Revenue: $285M - 315M.</li><li>Shares are down <font color=\"red\">3%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428424\" data-linked=\"Corcept sees Q4 revenue below consensus; shares down 3% after hours\" data-tweet=\"$CORT - Corcept sees Q4 revenue below consensus; shares down 3% after hours https://seekingalpha.com/news/3428424-corcept-sees-q4-revenue-below-consensus-shares-down-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3428424-corcept-sees-q4-revenue-below-consensus-shares-down-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428423\" data-ts=\"1548971583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YUMC\" target=\"_blank\">YUMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428423-yum-chinaplus-6-kfc-heavy-lifting-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yum China +6% as KFC does heavy lifting in Q4</a></h4><ul><li>Yum China (NYSE:<a href='https://seekingalpha.com/symbol/YUMC' title='Yum China'>YUMC</a>) reports total system sales rose <a href=\"https://seekingalpha.com/pr/17398504-yum-china-reports-fourth-quarter-fiscal-year-2018-results\" target=\"_blank\">6%</a> (ex-F/X), with 9% growth at KFC partially offset by a 2% decline at Pizza Hut.</li><li>Same-store sales were up 2% (ex-F/X) Y/Y, consisting of a 3% increase at KFC and a 4% decrease at Pizza Hut.</li><li>Operating profit was up 77% Y/Y to $47M.</li><li>Restaurant margin was 11.5% of sales during the quarter vs. 11.6% a year ago.</li><li>Shares of Yum China are <font color=\"green\">up 6.1%</font> in AH trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428386-yum-china-beats-0_03-misses-revenue\" target=\"_blank\">Yum China beats by $0.03, misses on revenue</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428423\" data-linked=\"Yum China +6% as KFC does heavy lifting in Q4\" data-tweet=\"$YUMC - Yum China +6% as KFC does heavy lifting in Q4 https://seekingalpha.com/news/3428423-yum-chinaplus-6-kfc-heavy-lifting-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3428423-yum-chinaplus-6-kfc-heavy-lifting-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428414\" data-ts=\"1548971334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CY\" target=\"_blank\">CY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428414-cypres-semiplus-4_5-on-q4-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cypres Semi +4.5% on Q4 beats</a></h4><ul><li>Cypress Semi (NASDAQ:<a href='https://seekingalpha.com/symbol/CY' title='Cypress Semiconductor Corporation'>CY</a>) <font color=\"green\">gains 4.5%</font> on Q4 beats with revenue up 1% Y/Y. Downside Q1 guidance has revenue at $550M (consensus: $558.78M) and EPS from $0.22 to $0.26 (consensus: $0.26).</li><li>Revenue by unit: MCD, $355.8M (-0.4% Y/Y); MPD, $248.7M (+3.5% Y/Y).</li><li><a href=\"https://seekingalpha.com/pr/17398388-cypress-reports-fourth-quarter-year-end-2018-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428326-cypress-semiconductor-beats-0_02-beats-revenue\" target=\"_blank\">Cypress Semiconductor beats by $0.02, beats on revenue</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428414\" data-linked=\"Cypres Semi +4.5% on Q4 beats\" data-tweet=\"$CY - Cypres Semi +4.5% on Q4 beats https://seekingalpha.com/news/3428414-cypres-semiplus-4_5-on-q4-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3428414-cypres-semiplus-4_5-on-q4-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428403\" data-ts=\"1548970923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYMC\" target=\"_blank\">SYMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428403-symantecplus-5-on-q3-beats-upside-fy-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Symantec +5% on Q3 beats, upside FY guide</a></h4><ul><li>Symantec (NASDAQ:<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>) <font color=\"green\">gains 5%</font> on Q3 beats with a 1% Y/Y revenue drop. In-line Q4 guidance has revenue from $1.19B to $1.22B (consensus: $1.21B) and EPS of $0.37 to $0.41 (consensus: $0.38).</li><li>Upside FY19 guidance has revenue from $4.76B to $4.79B (consensus: $4.74B) and EPS of $1.57 to $1.61 (consensus: $1.54).</li><li>Share repurchase: The board increases the existing authorization to $1.3B.</li><li>New CAO: SYMC appoints Matthew Brown, current VP of Finance and Corporate Controller, to the position of VP, Finance and CAO, effective immediately.</li><li>CFO change: EVP and CFO Nicholas Noviello <a href=\"https://seekingalpha.com/pr/17398468-symantec-announces-chief-financial-officer-transition-plan\" target=\"_blank\">will leave</a> in the coming months to pursue other opportunities. He will remain in the role until a replacement is found and help with the transition.</li><li>Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"https://investor.symantec.com/About/Investors/Events-and-Presentations/Events/default.aspx\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17398434-symantec-reports-fiscal-third-quarter-2019-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428366-symantec-declares-0_075-dividend\" target=\"_blank\">Symantec declares $0.075 dividend</a> (Jan. 31)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428360-symantec-beats-0_05-beats-revenue\" target=\"_blank\">Symantec beats by $0.05, beats on revenue</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428403\" data-linked=\"Symantec +5% on Q3 beats, upside FY guide\" data-tweet=\"$SYMC $NLOK - Symantec +5% on Q3 beats, upside FY guide https://seekingalpha.com/news/3428403-symantecplus-5-on-q3-beats-upside-fy-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3428403-symantecplus-5-on-q3-beats-upside-fy-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428402\" data-ts=\"1548970894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EW\" target=\"_blank\">EW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428402-edwards-lifesciences-q4-non-gaap-earnings-up-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Edwards Lifesciences Q4 non-GAAP earnings up 22%</a></h4><ul><li>Edwards Lifesciences (NYSE:<a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corp'>EW</a>) <a href=\"https://seekingalpha.com/pr/17398459-edwards-lifesciences-reports-fourth-quarter-results\" target=\"_blank\">Q4 results</a> ($M): Total sales: 977.7 (+10.0%); Transcatheter heart valves: 592.4 (+14.1%); Surgical Heart Valves: 207.2 (+1.1%); Critical Care: 178.1 (+8.4%).</li><li>Net income: 7.0 (+350.0%); non-GAAP net income: 248.6 (+22.3%); EPS: 0.03 (+400.0%); non-GAAP EPS: 1.17 (+24.5%).</li><li>Cash flow ops &#40;FY&#41;: 785.8 (+13.0%).</li><li><strong>Q1 guidance</strong>: Sales: $950M - 1,010M; non-GAAP EPS: $1.15 - 1.25.</li><li><strong>2019 guidance</strong>: Sales: $3.9B - 4.3B;  non-GAAP EPS: $5.05 - 5.30.</li><li>Shares are off <font color=\"red\">1%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428402\" data-linked=\"Edwards Lifesciences Q4 non-GAAP earnings up 22%\" data-tweet=\"$EW - Edwards Lifesciences Q4 non-GAAP earnings up 22% https://seekingalpha.com/news/3428402-edwards-lifesciences-q4-non-gaap-earnings-up-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3428402-edwards-lifesciences-q4-non-gaap-earnings-up-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428393\" data-ts=\"1548970478\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGII\" target=\"_blank\">DGII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428393-digi-internationalplus-2_4-on-swing-to-gain-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digi International +2.4% on swing to gain in Q1</a></h4><ul>   <li>Digi International (NASDAQ:<a href='https://seekingalpha.com/symbol/DGII' title='Digi International Inc.'>DGII</a>) is <font color=\"green\">up 2.4%</font> after hours following a swing to profit and beat on top and bottom lines in its fiscal Q1 results.</li>    <li>The company's net income was $4.7M, vs. a year-ago loss of $4.5M. On an adjusted basis, net income was $1.2M vs. a year-ago loss of $1.7M.</li>    <li>Revenues grew nearly 39% and EBITDA of $6.2M topped company guidance and more than doubled last year's $3M.</li>    <li>Revenue breakout: Product, $50.8M (up 32.1%); Services and solutions, $11.5M (up 76.9%).</li>    <li>Revenue by region: North America (primarily U.S.), $46.3M (up 57.9%); EMEA, $10.1M (down 0.5%); Asia, $5.08M (up 12.2%); Latin America, $794,000 (down 15%).</li>    <li>For Q2, it's guiding to revenue of $59M-$63M, EBITDA of $4.5M-$6.5M, and EPS of $0.01-$0.05.</li>    <li>For the full year, it now projects EPS of $0.30-$0.45, and reiterates expectations for revenues of $245M-$255M and EBITDA of $24M-$28M.</li>    <li><a href=\"http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&amp;c=108535&amp;eventID=5277029\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428333-digi-international-beats-0_05-beats-revenue\" target=\"_blank\">Digi International beats by $0.05, beats on revenue</a> (Jan. 31 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17398394-digi-international-reports-first-fiscal-quarter-2019-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3428393\" data-linked=\"Digi International +2.4% on swing to gain in Q1\" data-tweet=\"$DGII - Digi International +2.4% on swing to gain in Q1 https://seekingalpha.com/news/3428393-digi-internationalplus-2_4-on-swing-to-gain-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3428393-digi-internationalplus-2_4-on-swing-to-gain-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428386\" data-ts=\"1548970345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YUMC\" target=\"_blank\">YUMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428386-yum-china-beats-0_03-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yum China beats by $0.03, misses on revenue</a></h4><ul><li>Yum China (NYSE:<a href='https://seekingalpha.com/symbol/YUMC' title='Yum China'>YUMC</a>): Q4 Non-GAAP EPS of $0.12 <span style=\"color:green\">beats by $0.03</span>; GAAP EPS of $0.19 <span style=\"color:green\">beats by $0.13</span>.</li><li>Revenue of $1.91B (+2.1% Y/Y) <font color=\"red\">misses by $10M</font>.</li><li>Shares <font color=\"green\">+6.8%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17398504-yum-china-reports-fourth-quarter-fiscal-year-2018-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3428386\" data-linked=\"Yum China beats by $0.03, misses on revenue\" data-tweet=\"$YUMC - Yum China beats by $0.03, misses on revenue https://seekingalpha.com/news/3428386-yum-china-beats-0_03-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3428386-yum-china-beats-0_03-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428376\" data-ts=\"1548969852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428376-amazon-reports-holiday-beats-awsplus-46\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon reports holiday beats; AWS +46%</a></h4><ul><li>Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) reports Q4 results that beat EPS and revenue estimates with 20% Y/Y revenue growth. Note that Amazon has a mixed record with beating revenue estimates for its holiday quarter and sales were also underwhelming in Q3.</li><li>Q1 guidance has revenue from $50B to $60B (consensus: $60.87B) and operating income at $2.3B to $3.3B (consensus: $3.1B).</li><li>Revenue by region: North America, $44.1B (consensus: $44.23B); International, $20.8B (consensus: $20.49B); AWS, $7.4B (+46% Y/Y; consensus: $7.29B).</li><li>Revenue by product line: Online stores, $39.8B (consensus: $38.58B); Physical stores, $4.4B ($4.73B); Third-party seller services, $13.4B (consensus: $13.52B); Subscription services, $4B (consensus: $4.32B); Other, $3.4B (+95% Y/Y; consensus: $3.58B).</li><li>Operating income came in at $3.8B (consensus: $3.74B). Operating expenses were $68.6B, up about $10B from last year's quarter.</li><li>Earnings call is scheduled for 5:30 PM ET with a webcast available <a href=\"https://ir.aboutamazon.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17398365-amazon-com-announces-fourth-quarter-sales-20-percent-72_4-billion\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428319-amazon-beats-0_39-beats-revenue\" target=\"_blank\">Amazon beats by $0.39, beats on revenue</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428376\" data-linked=\"Amazon reports holiday beats; AWS +46%\" data-tweet=\"$AMZN - Amazon reports holiday beats; AWS +46% https://seekingalpha.com/news/3428376-amazon-reports-holiday-beats-awsplus-46?source=tweet\" data-url=\"https://seekingalpha.com/news/3428376-amazon-reports-holiday-beats-awsplus-46\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428362\" data-ts=\"1548969470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DECK\" target=\"_blank\">DECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428362-deckers-outdoorplus-8-after-blasting-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deckers Outdoor +8% after blasting estimates</a></h4><ul> <li>Deckers Outdoor (NASDAQ:<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a>) is trading higher after topping estimates with its <a href=\"https://seekingalpha.com/pr/17398391-deckers-brands-reports-third-quarter-fiscal-2019-financial-results-raises-guidance-full-year\" target=\"_blank\">FQ3</a> report.</li>  <li>UGG brand revenue increased 3.6% Y/Y to $761M during the quarter, while Hoka One revenue was up 79% to $57M.</li> <li>Operating income of $245M was recorded vs. $193M a year ago.</li>  <li>The retailer reports gross margin of 53.8% vs. 52.2% a year ago.</li>  <li>The company expects full-year revenue of $1.986B to $2.0B vs. $1.97B consensus and full-year EPS of $7.85 to $7.95 vs. $6.93 consensus.</li><li>Deckers said the board authorized an additional $261M to it share repurchase program.</li><li>DECK <font color=\"green\">+7.7%</font> AH to $136.00.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428329-deckers-outdoor-beats-1_30-beats-revenue\" target=\"_blank\">Deckers Outdoor beats by $1.30, beats on revenue</a> (Jan. 31)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3428362\" data-linked=\"Deckers Outdoor +8% after blasting estimates\" data-tweet=\"$DECK - Deckers Outdoor +8% after blasting estimates https://seekingalpha.com/news/3428362-deckers-outdoorplus-8-after-blasting-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3428362-deckers-outdoorplus-8-after-blasting-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428360\" data-ts=\"1548969393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYMC\" target=\"_blank\">SYMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428360-symantec-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Symantec beats by $0.05, beats on revenue</a></h4><ul><li>Symantec (NASDAQ:<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>): Q3 Non-GAAP EPS of $0.44 <span style=\"color:green\">beats by $0.05</span>; GAAP EPS of $0.10 <span style=\"color:green\">beats by $0.07</span>.</li><li>Revenue of $1.22B (-0.8% Y/Y) <font color=\"green\">beats by $40M</font>.</li><li>Shares <font color=\"green\">+5%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17398434-symantec-reports-fiscal-third-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3428360\" data-linked=\"Symantec beats by $0.05, beats on revenue\" data-tweet=\"$SYMC $NLOK - Symantec beats by $0.05, beats on revenue https://seekingalpha.com/news/3428360-symantec-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3428360-symantec-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428329\" data-ts=\"1548968858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DECK\" target=\"_blank\">DECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428329-deckers-outdoor-beats-1_30-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deckers Outdoor beats by $1.30, beats on revenue</a></h4><ul><li>Deckers Outdoor (NASDAQ:<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a>): Q3 Non-GAAP EPS of $6.59 <span style=\"color:green\">beats by $1.30</span>; GAAP EPS of $6.68 <span style=\"color:green\">beats by $1.34</span>.</li><li>Revenue of $873.8M (+7.8% Y/Y) <font color=\"green\">beats by $50.94M</font>.</li><li>Shares <font color=\"green\">+5.1%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17398391-deckers-brands-reports-third-quarter-fiscal-2019-financial-results-raises-guidance-full-year\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3428329\" data-linked=\"Deckers Outdoor beats by $1.30, beats on revenue\" data-tweet=\"$DECK - Deckers Outdoor beats by $1.30, beats on revenue https://seekingalpha.com/news/3428329-deckers-outdoor-beats-1_30-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3428329-deckers-outdoor-beats-1_30-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428319\" data-ts=\"1548968565\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428319-amazon-beats-0_39-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon beats by $0.39, beats on revenue</a></h4><ul><li>Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>): Q4 GAAP EPS of $6.04 <span style=\"color:green\">beats by $0.39</span>.</li><li>Revenue of $72.4B (+19.8% Y/Y) <font color=\"green\">beats by $520M</font>.</li><li>Shares <font color=\"green\">+3%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17398365-amazon-com-announces-fourth-quarter-sales-20-percent-72_4-billion\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3428319\" data-linked=\"Amazon beats by $0.39, beats on revenue\" data-tweet=\"$AMZN - Amazon beats by $0.39, beats on revenue https://seekingalpha.com/news/3428319-amazon-beats-0_39-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3428319-amazon-beats-0_39-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>141&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428314\" data-ts=\"1548968520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKX\" target=\"_blank\">SKX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428314-late-day-spike-in-skechers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Late day spike in Skechers</a></h4><ul><li>Shares of Skechers (<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='green'>+12%</font>) were halted due to volatility after a huge late-day spike.</li><li>The big jump in Skechers came without any official news out from the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428314\" data-linked=\"Late day spike in Skechers\" data-tweet=\"$SKX - Late day spike in Skechers https://seekingalpha.com/news/3428314-late-day-spike-in-skechers?source=tweet\" data-url=\"https://seekingalpha.com/news/3428314-late-day-spike-in-skechers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428307\" data-ts=\"1548966701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLO\" target=\"_blank\">VLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428307-valero-looking-for-alternatives-stops-buying-venezuelan-crude\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valero looking for alternatives as it stops buying Venezuelan crude</a></h4><ul><li>Valero Energy (<a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color='green'>+5.2%</font>) confirms it is <a href=\"https://finance.yahoo.com/news/valero-holes-supply-plan-venezuelan-161900622.html\" target=\"_blank\">not taking any more deliveries</a> of Venezuelan crude but says it is well prepared for the sanctions imposed by the U.S. government.</li><li>VLO began buying replacement barrels from heavy oil suppliers in Canada as recently as the start of this week, Bloomberg reports; for now, covering a 30-day supply plan is the company's top priority, Gary Simmons, senior VP of supply for international operations, said during today's earnings conference call.</li><li>\"We\u2019re in a lot better position today than we were on Tuesday but we still have some holes to fill in our supply plan,\" Simmons said, adding that the full impact of the sanctions has been muted somewhat by maintenance work at a Louisiana refinery that has reduced the amount of oil the company needs to buy.</li><li>VLO also has been <a href=\"https://www.reuters.com/article/us-valero-energy-results/valero-beats-on-profit-has-stopped-buying-venezuela-crude-idUSKCN1PP1F5\" target=\"_blank\">substituting light crude oil</a> from North America and other sources, and CEO Joseph Gorder said \"the current economics are certainly pushing the country to maximize light sweet in the system.\"</li><li>VLO, which also has been investing heavily in pipelines and storage to reduce costs, said the completion of some projects provided it with greater access to discounted North American crudes during Q4.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428307\" data-linked=\"Valero looking for alternatives as it stops buying Venezuelan crude\" data-tweet=\"$VLO - Valero looking for alternatives as it stops buying Venezuelan crude https://seekingalpha.com/news/3428307-valero-looking-for-alternatives-stops-buying-venezuelan-crude?source=tweet\" data-url=\"https://seekingalpha.com/news/3428307-valero-looking-for-alternatives-stops-buying-venezuelan-crude\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428305\" data-ts=\"1548966624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRB\" target=\"_blank\">HRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428305-h-and-r-block-slumps-after-goldman-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">H&amp;R Block slumps after Goldman cut</a></h4><ul><li>H&amp;R Block (<a href='https://seekingalpha.com/symbol/HRB' title='H&R Block Inc.'>HRB</a> <font color='red'>-7.7%</font>) slumps after Goldman Sachs lowers its rating to Sell from Neutral ahead of the tax season.</li><li>GS warns that tax reform has structurally changed the tax preparation season.</li><li>The firm drops its price target to $22.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428305\" data-linked=\"H&amp;R Block slumps after Goldman cut\" data-tweet=\"$HRB - H&amp;R Block slumps after Goldman cut https://seekingalpha.com/news/3428305-h-and-r-block-slumps-after-goldman-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3428305-h-and-r-block-slumps-after-goldman-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428299\" data-ts=\"1548965454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MUSA\" target=\"_blank\">MUSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428299-post-earnings-swoon-for-murphy-usa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings swoon for Murphy USA</a></h4><ul><li>Shares of Murphy USA (<a href='https://seekingalpha.com/symbol/MUSA' title='Murphy USA, Inc.'>MUSA</a> <font color='red'>-9.4%</font>) fall after the company falls short with Q4 EBITDA.</li><li>Despite the Q4 shortfall, company management noted during the post-earnings conference call that full-year adjusted EBITDA of about $412M landed at the midpoint of its annual guidance range.</li><li><a href=\"https://seekingalpha.com/article/4237199-murphy-usa-inc-musa-ceo-andrew-clyde-q4-2018-results-earnings-call-transcript\" target=\"_blank\">Murphy USA conference call</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3427841-murphy-usa-misses-0_24-beats-revenue\" target=\"_blank\">Murphy USA misses by $0.24, beats on revenue</a> (Jan. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428299\" data-linked=\"Post-earnings swoon for Murphy USA\" data-tweet=\"$MUSA - Post-earnings swoon for Murphy USA https://seekingalpha.com/news/3428299-post-earnings-swoon-for-murphy-usa?source=tweet\" data-url=\"https://seekingalpha.com/news/3428299-post-earnings-swoon-for-murphy-usa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428293\" data-ts=\"1548964534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SILC\" target=\"_blank\">SILC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428293-technology-top-5-gainers-losers-of-3_00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3.00 PM</a></h4><ul><li><strong>Gainers:</strong> Silicom (NASDAQ:<a href='https://seekingalpha.com/symbol/SILC' title='Silicom Ltd'>SILC</a>) <font color=\"green\">+21%</font>. Pixelworks (NASDAQ:<a href='https://seekingalpha.com/symbol/PXLW' title='Pixelworks, Inc.'>PXLW</a>) <font color=\"green\">+16%</font>. NIC (NASDAQ:<a href='https://seekingalpha.com/symbol/EGOV' title='NIC Inc.'>EGOV</a>) <font color=\"green\">+15%</font>. II-VI Incorporated (NASDAQ:<a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a>) <font color=\"green\">+14%</font>. GCI Liberty (NASDAQ:<a href='https://seekingalpha.com/symbol/GLIBA' title='GCI Liberty A'>GLIBA</a>) <font color=\"green\">+14%</font>.</li> <li><strong>Losers:</strong> KEMET Corporation (NYSE:<a href='https://seekingalpha.com/symbol/KEM' title='KEMET Corp.'>KEM</a>) <font color=\"red\">-18%</font>. Nano Dimension (NASDAQ:<a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a>) <font color=\"red\">-10%</font>. GTT Communications (NYSE:<a href='https://seekingalpha.com/symbol/GTT' title='GTT Communications, Inc.'>GTT</a>) <font color=\"red\">-7%</font>. The9 Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a>) <font color=\"red\">-7%</font>. SMTC (NASDAQ:<a href='https://seekingalpha.com/symbol/SMTX' title='SMTC Corporation'>SMTX</a>) <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428293\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3.00 PM\" data-tweet=\"$SILC $SILC $PXLW - Technology - Top 5 Gainers / Losers as of 3.00 PM https://seekingalpha.com/news/3428293-technology-top-5-gainers-losers-of-3_00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3428293-technology-top-5-gainers-losers-of-3_00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428285\" data-ts=\"1548964032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428285-geplus-13-culps-candor-sparks-relief-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE +13% as Culp&#39;s candor sparks relief rally</a></h4><ul><li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color=\"green\">+13.1%</font>) soars to its highest in three months even after missing <a href=\"https://seekingalpha.com/news/3428027-ge-plus-7_4-percent-sales-beat-doj-settlement\" target=\"_blank\">Q4 earnings</a> estimates, as investor sentiment is warmed by CEO Larry Culp's suggestion that <a href=\"https://www.marketwatch.com/story/ges-stock-gets-biggest-earnings-boost-in-over-10-years-2019-01-31\" target=\"_blank\">the worst is nearly over</a> for the company's struggling power business.</li><li>Culp said during today's earnings conference call that while he expects the power business to continue to face headwinds, he believes they will represent a \"high-water mark\" this year and then \"come down substantially\" over the next few years.</li><li>Culp cautioned that <a href=\"https://www.wsj.com/articles/ges-power-unit-weighs-on-fourth-quarter-results-subprime-probe-settled-11548936549\" target=\"_blank\">GE's cash flow in 2019 would be hurt</a> by restructuring, charges related to its power business, investments in its health care spinoff and other one-time items, but cash flow should grow substantially in 2020 and 2021.</li><li>\"I think for a number of investors, the absence of yet another negative surprise is perhaps very much a part of the story,\" Culp tells <em>WSJ</em>.</li><li>Some say <a href=\"https://www.reuters.com/article/us-ge-results/general-electrics-modest-gains-candor-spark-relief-rally-idUSKCN1PP1DM\" target=\"_blank\">Culp\u2019s candor</a> on the earnings call went a long way to restoring credibility after years of happy talk; \u201cPower is still in free-fall,\u201d says Melius research analyst Scott Davis. But GE is providing \"an honest assessment of the problems and (a) realistic plan to fix them... So the relief rally is explainable.\"</li><li>CFRA analyst Jim Corridore reiterates his buy rating on GE and raises his price target to $13 from $11, saying \"we expect a GE fix to take time, but today\u2019s results show some much needed progress.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3428285\" data-linked=\"GE +13% as Culp&#39;s candor sparks relief rally\" data-tweet=\"$GE - GE +13% as Culp&#39;s candor sparks relief rally https://seekingalpha.com/news/3428285-geplus-13-culps-candor-sparks-relief-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/3428285-geplus-13-culps-candor-sparks-relief-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>85&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428277\" data-ts=\"1548963392\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APRN\" target=\"_blank\">APRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428277-blue-apronminus-3-after-guidance-update-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blue Apron -3% after guidance update disappoints</a></h4><ul> <li>Blue Apron (NYSE:<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a>) is <font color=\"red\">down 3.2%</font> a day after reporting a Q4 earnings beat.</li> <li>On the radar of traders is management disclosure on the earnings conference call that Blue Apron expects a net loss of $11M to $14M in Q1 and a narrower overall loss in 2019 than was seen in 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3427856-blue-apron-plus-4-percent-earnings-topper\" target=\"_blank\">Blue Apron +4% after earnings topper</a> (Jan. 30)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3428277\" data-linked=\"Blue Apron -3% after guidance update disappoints\" data-tweet=\"$APRN - Blue Apron -3% after guidance update disappoints https://seekingalpha.com/news/3428277-blue-apronminus-3-after-guidance-update-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3428277-blue-apronminus-3-after-guidance-update-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428267\" data-ts=\"1548961099\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGO\" target=\"_blank\">EGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428267-eldorado-gold-and-ferrellgas-partners-among-energy-materials-gainers-dowdupont-and-cnx\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eldorado Gold and Ferrellgas Partners among Energy/Materials gainers; DowDuPont and CNX Resources among losers</a></h4><ul><li><b>Gainers: </b>Eldorado Gold (NYSE:<a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a>) <font color=\"green\">+25%</font>. Ferrellgas Partners (NYSE:<a href='https://seekingalpha.com/symbol/FGP' title='Ferrellgas Partners L.P'>FGP</a>) <font color=\"green\">+13%</font>. Lilis Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a>) <font color=\"green\">+10%</font>. Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"green\">+6%</font>. SAExploration (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>DowDuPont (NYSE:<a href='https://seekingalpha.com/symbol/DWDP' title='DowDuPont Inc.'>DWDP</a>) <font color=\"red\">-8%</font>. CNX Resources (NYSE:<a href='https://seekingalpha.com/symbol/CNX' title='CNX Resources Corporation'>CNX</a>) <font color=\"red\">-8%</font>. CNX Midstream Partners (NYSE:<a href='https://seekingalpha.com/symbol/CNXM' title='CNX Midstream Partners LP'>CNXM</a>) <font color=\"red\">-8%</font>. CARBO Ceramics (NYSE:<a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>) <font color=\"red\">-7%</font>. Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428267\" data-linked=\"Eldorado Gold and Ferrellgas Partners among Energy/Materials gainers; DowDuPont and CNX Resources among losers\" data-tweet=\"$EGO $EGO $FGP - Eldorado Gold and Ferrellgas Partners among Energy/Materials gainers; DowDuPont and CNX Resources among losers https://seekingalpha.com/news/3428267-eldorado-gold-and-ferrellgas-partners-among-energy-materials-gainers-dowdupont-and-cnx?source=tweet\" data-url=\"https://seekingalpha.com/news/3428267-eldorado-gold-and-ferrellgas-partners-among-energy-materials-gainers-dowdupont-and-cnx\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428264\" data-ts=\"1548960419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CACC\" target=\"_blank\">CACC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428264-credit-acceptanceminus-2_8-after-only-bull-steps-aside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Acceptance -2.8% after only bull steps aside</a></h4><ul><li>Credit Acceptance Corp. (NASDAQ:<a href='https://seekingalpha.com/symbol/CACC' title='Credit Acceptance Corporation'>CACC</a>) <font color=\"red\">sinks 2.8%</font> after Oppenheimer analyst Dominick Gabriele downgrades the stock to perform from outperform and removes $437 price target.</li><li>Says dealer penetration is pressuring loan growth and it will be hard to re-accelerate growth in the near-term without ramping up staff levels, he writes.</li><li>Still likes the long-term business model and calls CACC \"one of the best subprime lenders in the business.\"</li><li><a href=\"https://seekingalpha.com/symbol/CACC/earnings/analyst_ratings\" target=\"_blank\">Analyst ratings</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3427885-credit-acceptance-plus-2_6-percent-q4-beat\" target=\"_blank\">Credit Acceptance +2.6% after Q4 beat</a> (Jan. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428264\" data-linked=\"Credit Acceptance -2.8% after only bull steps aside\" data-tweet=\"$CACC - Credit Acceptance -2.8% after only bull steps aside https://seekingalpha.com/news/3428264-credit-acceptanceminus-2_8-after-only-bull-steps-aside?source=tweet\" data-url=\"https://seekingalpha.com/news/3428264-credit-acceptanceminus-2_8-after-only-bull-steps-aside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428263\" data-ts=\"1548960306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428263-qualcomm-asks-german-court-to-fine-apple\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm asks German court to fine Apple</a></h4><ul><li>Qualcomm (<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a> <font color='red'>-1.4%</font>) asks a Munich court to fine Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='green'>+1.1%</font>) for not fully complying with <a href=\"https://seekingalpha.com/news/3418483-apple-faces-iphone-ban-germany-update\" target=\"_blank\">an injunction</a> from December.</li><li>In its filed motion, Qualcomm says Apple didn't properly recall iPhones from sellers, and devices remained in Apple's retail stores earlier this month.</li><li>Qualcomm says Apple \"obviously don\u2019t consider themselves bound by the injunction\" and should receive significant fines \"to put a check on that.\"</li><li>QCOM cites Apple's post-injunction press release, which said iPhones would be available through other retailers, as evidence of non-compliance. The court later told Apple to <a href=\"https://seekingalpha.com/news/3424345-munich-court-tells-apple-retract-statement-update\" target=\"_blank\">retract </a>the statement.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428213-german-court-tosses-qualcomm-patents\" target=\"_blank\">German court tosses Qualcomm patents</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428263\" data-linked=\"Qualcomm asks German court to fine Apple\" data-tweet=\"$QCOM $QCOM $AAPL - Qualcomm asks German court to fine Apple https://seekingalpha.com/news/3428263-qualcomm-asks-german-court-to-fine-apple?source=tweet\" data-url=\"https://seekingalpha.com/news/3428263-qualcomm-asks-german-court-to-fine-apple\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>72&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428259\" data-ts=\"1548959647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/V\" target=\"_blank\">V</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428259-visa-slips-concerns-q2-trends-emerge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Visa slips as concerns about Q2 trends emerge</a></h4><ul><li>Visa (NYSE:<a href='https://seekingalpha.com/symbol/V' title='Visa Inc.'>V</a>) <font color=\"red\">slides 2.3%</font> as analysts digest the company's fiscal Q1 results and last night's call.</li><li>Though both top- and bottom-line results beat consensus estimates, slower U.S. payment volumes and cross-border growth may be a concern, say some analysts.</li><li>Management comments on Q2 trends raise concerns about the rest of the fiscal year, according to Buckingham Research Group analyst Chris Brendler, who maintains a Buy rating.</li><li>Susquehanna analyst James Friedman sees several factors affecting Q2 including forex headwind, low-single-digit cross-border growth in first three weeks, client incentive shift to Q2 from Q1 on delayed deals, and macro volatility. He keeps his rating as Positive.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3427857-visa-plus-2_2-percent-q1-gains-payments-volume-growth\" target=\"_blank\">Visa +2.2% as Q1 gains on payments volume growth</a> (Jan. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428259\" data-linked=\"Visa slips as concerns about Q2 trends emerge\" data-tweet=\"$V - Visa slips as concerns about Q2 trends emerge https://seekingalpha.com/news/3428259-visa-slips-concerns-q2-trends-emerge?source=tweet\" data-url=\"https://seekingalpha.com/news/3428259-visa-slips-concerns-q2-trends-emerge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428256\" data-ts=\"1548958633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSC\" target=\"_blank\">MSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428256-studio-cityplus-10-after-peers-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Studio City +10% after peers report</a></h4><ul><li>Shares of Studio City International (NYSE:<a href='https://seekingalpha.com/symbol/MSC' title='Studio City International Holdings'>MSC</a>) shoot <font color=\"green\">up 9.9%</font> after strong results from Wynn Resorts and Las Vegas Sands this week boost sentiment.</li><li>Stronger-than-anticipated demand from the Macau mass market has been a theme this week with the casino sector.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428256\" data-linked=\"Studio City +10% after peers report\" data-tweet=\"$MSC - Studio City +10% after peers report https://seekingalpha.com/news/3428256-studio-cityplus-10-after-peers-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3428256-studio-cityplus-10-after-peers-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428254\" data-ts=\"1548958481\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MHLD\" target=\"_blank\">MHLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428254-maiden-holdings-leads-financial-gainers-amalgamated-bank-and-waterstone-financial-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maiden Holdings leads financial gainers; Amalgamated Bank and Waterstone Financial among losers</a></h4><ul><li><b>Gainers: </b>Maiden Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a>) <font color=\"green\">+12%</font>. Banco Bradesco (NYSE:<a href='https://seekingalpha.com/symbol/BBD' title='Banco Bradesco, S.A.'>BBD</a>) <font color=\"green\">+7%</font>. Cushman &amp; Wakefield (NYSE:<a href='https://seekingalpha.com/symbol/CWK' title='Cushman & Wakefield'>CWK</a>) <font color=\"green\">+6%</font>. Apollo Global Management (NYSE:<a href='https://seekingalpha.com/symbol/APO' title='Apollo Global Management, LLC'>APO</a>) <font color=\"green\">+5%</font>. Drive Shack (NYSE:<a href='https://seekingalpha.com/symbol/DS' title='Drive Shack Inc'>DS</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Greenhill &amp; Co (NYSE:<a href='https://seekingalpha.com/symbol/GHL' title='Greenhill & Co., Inc.'>GHL</a>) <font color=\"red\">-14%</font>. Nomura Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NMR' title='Nomura Holdings, Inc.'>NMR</a>) <font color=\"red\">-7%</font>. Amalgamated Bank (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAL' title='Amalgamated Bank'>AMAL</a>) <font color=\"red\">-6%</font>. Waterstone Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/WSBF' title='Waterstone Financial, Inc.'>WSBF</a>) <font color=\"red\">-5%</font>. World Acceptance (NASDAQ:<a href='https://seekingalpha.com/symbol/WRLD' title='World Acceptance Corporation'>WRLD</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428254\" data-linked=\"Maiden Holdings leads financial gainers; Amalgamated Bank and Waterstone Financial among losers\" data-tweet=\"$MHLD $MHLD $BBD - Maiden Holdings leads financial gainers; Amalgamated Bank and Waterstone Financial among losers https://seekingalpha.com/news/3428254-maiden-holdings-leads-financial-gainers-amalgamated-bank-and-waterstone-financial-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3428254-maiden-holdings-leads-financial-gainers-amalgamated-bank-and-waterstone-financial-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428253\" data-ts=\"1548957981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNA\" target=\"_blank\">MRNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428253-moderna-up-15-on-mrnaminus-2752-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moderna up 15% on mRNA-2752 data</a></h4><ul><li>Moderna (<a href='https://seekingalpha.com/symbol/MRNA' title='Moderna, Inc.'>MRNA</a> <font color=\"green\">+14.6%</font>) is up on average volume, adding to its nascent rally. Shares have risen over <font color=\"green\">20%</font> since Tuesday.</li><li>Yesterday, it <a href=\"https://seekingalpha.com/pr/17396552-newly-published-pre-clinical-data-show-intratumoral-injections-messenger-rna-encoding-three\" target=\"_blank\">announced </a>the publication of preclinical data in <em>Science Translational Medicine</em> on pipeline candidate mRNA-2752. Results from a mouse study showed a broad immune response promoting tumor regression in both injected lesions and distant un-uninjected tumors. When combined with checkpoint inhibitors, mRNA-2752 increased complete response rates in immunosuppressive and immunologically barren tumor models that were otherwise unresponsive to checkpoint inhibitor therapy.</li><li>An open-label <a href=\"https://clinicaltrials.gov/ct2/show/NCT03739931\" target=\"_blank\">Phase 1 study</a> evaluating mRNA-2752, combined with AstraZeneca's (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color=\"green\">+1.7%</font>) IMFINZI (durvalumab) or tremelimumab, in patients with advanced/metastatic solid tumors or lymphoma is in process. The estimated primary completion date is August 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428253\" data-linked=\"Moderna up 15% on mRNA-2752 data\" data-tweet=\"$MRNA $MRNA $AZN - Moderna up 15% on mRNA-2752 data https://seekingalpha.com/news/3428253-moderna-up-15-on-mrnaminus-2752-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3428253-moderna-up-15-on-mrnaminus-2752-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428252\" data-ts=\"1548957509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDS.A\" target=\"_blank\">RDS.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428252-royal-dutch-shellplus-4-full-year-profit-hits-highest-since-2014\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Royal Dutch Shell +4% as full-year profit hits highest since 2014</a></h4><ul><li>Royal Dutch Shell (<a href='https://seekingalpha.com/symbol/RDS.A' title='Royal Dutch Shell plc'>RDS.A</a> <font color='green'>+3.7%</font>) shares maintain strong gains after the company reported better than expected <a href=\"https://seekingalpha.com/news/3427932-royal-dutch-shell-beats-0_07-beats-revenue\" target=\"_blank\">Q4 earnings</a> and revenues, and as FY 2018 profit on a cost-of-supplies basis totaled $23.8B, its <a href=\"https://www.wsj.com/articles/shell-profit-doubles-as-disciplined-approach-pays-off-11548930434\" target=\"_blank\">highest level since the 2014 crude oil price crash</a>.</li><li>Free cash flow jumped 42% Y/Y to $39.4B from $27.6B a year earlier, when Shell suffered losses on hedging for liquefied natural gas shipments.</li><li>\"<a href=\"https://uk.reuters.com/article/uk-shell-results/shell-vows-spending-discipline-even-as-2018-profits-soar-idUKKCN1PP0OJ\" target=\"_blank\">The cash flow is incredible</a>,\" says Redburn analyst Rob West. \"It\u2019s heavily flattered by downstream inventory liquidation, but it still squashes any lingering worries about debt and dividend coverage.\"</li><li>Shell\u2019s 2018 capex climbed to $23B from $20.8B a year earlier due to investments in exploration and joint ventures, but Richard Hunter, head of markets at Interactive Investor, says he is \"not overly concerned... By streamlining their operation in the last few years, Shell have given themselves flexibility and the slight increase in capital expenditure is one of the fallout.\"</li><li>Q4 total oil and gas production of 3.79M boe/day rose 1% Y/Y, and full-year production also was little changed at 3.67M boe/day.</li><li>Shell says it expects Q1 integrated gas production to fall by 140K-170K boe/day, mainly due to divestments and the transfer of  some activities into the main upstream segment.</li><li>\"We will continue with a strong delivery focus in 2019, with a disciplined approach to capital investment,\" CEO Ben van Beurden said.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428252\" data-linked=\"Royal Dutch Shell +4% as full-year profit hits highest since 2014\" data-tweet=\"$RDS.A $RDS.B - Royal Dutch Shell +4% as full-year profit hits highest since 2014 https://seekingalpha.com/news/3428252-royal-dutch-shellplus-4-full-year-profit-hits-highest-since-2014?source=tweet\" data-url=\"https://seekingalpha.com/news/3428252-royal-dutch-shellplus-4-full-year-profit-hits-highest-since-2014\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428245\" data-ts=\"1548956124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBIO\" target=\"_blank\">FBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428245-healthcare-tops-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare tops midday movers</a></h4><ul><li><strong>Gainers: </strong>Fortress Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a>) <font color=\"green\">+41%</font>. MeiraGTx Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MGTX' title='MeiraGTx Holdings plc'>MGTX</a>) <font color=\"green\">+29%</font>. Eldorado Gold (NYSE:<a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a>) <font color=\"green\">+23%</font>. Avon Products (NYSE:<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>) <font color=\"green\">+22%</font>. Silicom (NASDAQ:<a href='https://seekingalpha.com/symbol/SILC' title='Silicom Ltd'>SILC</a>) <font color=\"green\">+20%</font>. Onconova Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a>) <font color=\"green\">+20%</font>. 1-800-FLOWERS.COM (NASDAQ:<a href='https://seekingalpha.com/symbol/FLWS' title='1-800 FLOWERS.COM, Inc.'>FLWS</a>) <font color=\"green\">+19%</font>. Tuesday Morning (NASDAQ:<a href='https://seekingalpha.com/symbol/TUES' title='Tuesday Morning Corp.'>TUES</a>) <font color=\"green\">+18%</font>. China SXT Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SXTC' title='China SXT Pharmaceuticals, Inc.'>SXTC</a>) <font color=\"green\">+18%</font>. Payment Data Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/PYDS' title='Payment Data Systems, Inc.'>PYDS</a>) <font color=\"green\">+18%</font>.</li> <li><strong>Losers: </strong>AVEO Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a>) <font color=\"red\">-57%</font>. Co-Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics'>CODX</a>) <font color=\"red\">-39%</font>. Net 1 UEPS Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>) <font color=\"red\">-32%</font>. Cimpress N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/CMPR' title='Cimpress N.V.'>CMPR</a>) <font color=\"red\">-25%</font>. KEMET Corporation (NYSE:<a href='https://seekingalpha.com/symbol/KEM' title='KEMET Corp.'>KEM</a>) <font color=\"red\">-18%</font>. Resolute Forest Products (NYSE:<a href='https://seekingalpha.com/symbol/RFP' title='Resolute Forest Products, Inc.'>RFP</a>) <font color=\"red\">-17%</font>. Greenhill &amp; Co. (NYSE:<a href='https://seekingalpha.com/symbol/GHL' title='Greenhill & Co., Inc.'>GHL</a>) <font color=\"red\">-14%</font>. China Advanced Construction Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/CADC' title='China Advanced Construction Materials Group, Inc.'>CADC</a>) <font color=\"red\">-10%</font>. Achaogen (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a>) <font color=\"red\">-10%</font>. Innoviva (NASDAQ:<a href='https://seekingalpha.com/symbol/INVA' title='Innoviva, Inc.'>INVA</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428245\" data-linked=\"Healthcare tops midday movers\" data-tweet=\"$FBIO $FBIO $MGTX - Healthcare tops midday movers https://seekingalpha.com/news/3428245-healthcare-tops-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3428245-healthcare-tops-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428243\" data-ts=\"1548956066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCO\" target=\"_blank\">CMCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428243-on-columbus-mckinnons-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Columbus McKinnon&#39;s Q3 results</a></h4><ul><li>Columbus McKinnon (<a href='https://seekingalpha.com/symbol/CMCO' title='Columbus McKinnon Corporation'>CMCO</a> <font color=\"green\">+0.5%</font>) reports Q3 revenue growth of 4.2% Y/Y to $217.4M, with U.S. sales of $116M (+7.3% Y/Y) and Non-U.S. sales of $101.4M (+0.8% Y/Y).</li><li>Q3 Gross margin <font color=\"green\">improved by 90 bps</font> to 33.8%; operating margin <font color=\"red\">declined by 350 bps </font>to 3.1%; and Adj. operating margin <font color=\"green\">improved by 200 bps</font> to 10.5%.</li><li>Adj. EBITDA increased 14.6% Y/Y to $30.8M and margin <font color=\"green\">improved by 130 bps</font> to 14.2%.</li><li>Q3 Expenses: Selling $23.86M (-6.3% Y/Y); G&amp;A $20.38M (-8.7% Y/Y) and R&amp;D $3.17M (-0.7% Y/Y).</li><li>Net cash provided by operating activities was $26.2M, compared to $16.5M a year ago. Company reported Operating cash flow of $23.8M.</li><li>Company has Cash, cash equivalents, and restricted cash of $58.33M, as of December 31, 2018.</li><li><strong>4Q19 Guidance:</strong> Company expects sales growth to be ~4% to 5%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3427981-columbus-mckinnon-beats-0_02-beats-revenue\" target=\"_blank\">Columbus McKinnon beats by $0.02, beats on revenue</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428243\" data-linked=\"More on Columbus McKinnon&#39;s Q3 results\" data-tweet=\"$CMCO - More on Columbus McKinnon&#39;s Q3 results https://seekingalpha.com/news/3428243-on-columbus-mckinnons-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3428243-on-columbus-mckinnons-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428241\" data-ts=\"1548955309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTEK\" target=\"_blank\">TTEK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428241-tetra-techplus-9-after-q1-earnings-beat-upside-q2-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tetra Tech +9% after Q1 earnings beat, upside Q2 guidance</a></h4><ul><li>Tetra Tech (<a href='https://seekingalpha.com/symbol/TTEK' title='Tetra Tech, Inc.'>TTEK</a> <font color='green'>+9.5%</font>) shoots higher after beating <a href=\"https://seekingalpha.com/news/3427757-tetra-tech-beats-0_08-misses-revenue\" target=\"_blank\">FQ1 earnings</a> expectations and guiding Q2 earnings above consensus.</li><li>TTEK says it achieved its best Q1 in the company's history with record net revenue, operating income and adjusted EPS, and new project wins in the quarter drove its backlog to an all-time record of $2.79B, up 15% Y/Y, and \"provides great visibility for the remainder of the fiscal year.\"</li><li>TTEK sees Q2 EPS of $0.61-$0.66 vs. $0.59 analyst consensus estimate and revenues of $520M-$570M vs. $545M consensus.</li><li>For FY 2019, TTEK issues in-line guidance, seeing EPS of $2.80-$2.95 vs. $2.87 consensus and prior guidance of $2.75-$2.95, and revenues of $2.2B-$2.4B vs. $2.28B consensus.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428241\" data-linked=\"Tetra Tech +9% after Q1 earnings beat, upside Q2 guidance\" data-tweet=\"$TTEK - Tetra Tech +9% after Q1 earnings beat, upside Q2 guidance https://seekingalpha.com/news/3428241-tetra-techplus-9-after-q1-earnings-beat-upside-q2-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3428241-tetra-techplus-9-after-q1-earnings-beat-upside-q2-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428239\" data-ts=\"1548954712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENTX\" target=\"_blank\">ENTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428239-entera-bio-advancing-osteoporosis-candidate-ebminus-613-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Entera Bio advancing osteoporosis candidate EB-613; shares up 3%</a></h4><ul><li>Entera Bio (<a href='https://seekingalpha.com/symbol/ENTX' title='Entera Bio'>ENTX</a> <font color=\"green\">+2.5%</font>) is set to <a href=\"https://seekingalpha.com/pr/17397340-entera-bio-announces-positive-feedback-guidance-us-fda-regarding-development-plans-oral-pth\" target=\"_blank\">launch </a>a dose-ranging study in H1 evaluating its oral parathyroid hormone &#40;PTH&#41; (EB-613) in ~140 osteoporosis patients.</li><li>The optimal dose will be used in a pivotal Phase 3 trial, expected to start in 2020, comparing EB-613 to Eli Lilly's (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color=\"green\">+2.2%</font>) injectable <a href=\"https://www.forteo.com/\" target=\"_blank\">FORTEO </a>(teriparatide) over a 12-month treatment period. The company says the FDA is on board with using bone mineral density as the primary endpoint instead of the incidence of bone fractures which will significantly shorten the study at a much lower cost.</li><li>If all goes well, marketing applications will follow.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428239\" data-linked=\"Entera Bio advancing osteoporosis candidate EB-613; shares up 3%\" data-tweet=\"$ENTX $ENTX $LLY - Entera Bio advancing osteoporosis candidate EB-613; shares up 3% https://seekingalpha.com/news/3428239-entera-bio-advancing-osteoporosis-candidate-ebminus-613-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3428239-entera-bio-advancing-osteoporosis-candidate-ebminus-613-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428235\" data-ts=\"1548954052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVP\" target=\"_blank\">AVP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428235-avon-products-leads-consumer-gainers-resolute-forest-products-and-orchids-paper-products-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avon Products leads consumer gainers; Resolute Forest Products and Orchids Paper Products in losers</a></h4><ul><li><b>Gainers: </b>Avon Products (NYSE:<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>) <font color=\"green\">+21%</font>. Pyxus International (NYSE:<a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a>) <font color=\"green\">+12%</font>. Ferrari (NYSE:<a href='https://seekingalpha.com/symbol/RACE' title='Ferrari N.V.'>RACE</a>) <font color=\"green\">+11%</font>. Aptiv (NYSE:<a href='https://seekingalpha.com/symbol/APTV' title='Aptiv PLC'>APTV</a>) <font color=\"green\">+8%</font>. Koss (NASDAQ:<a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Resolute Forest Products (NYSE:<a href='https://seekingalpha.com/symbol/RFP' title='Resolute Forest Products, Inc.'>RFP</a>) <font color=\"red\">-16%</font>. Orchids Paper Products (NYSEMKT:<a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428235\" data-linked=\"Avon Products leads consumer gainers; Resolute Forest Products and Orchids Paper Products in losers\" data-tweet=\"$AVP $AVP $PYX - Avon Products leads consumer gainers; Resolute Forest Products and Orchids Paper Products in losers https://seekingalpha.com/news/3428235-avon-products-leads-consumer-gainers-resolute-forest-products-and-orchids-paper-products-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3428235-avon-products-leads-consumer-gainers-resolute-forest-products-and-orchids-paper-products-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428230\" data-ts=\"1548953675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WRLD\" target=\"_blank\">WRLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428230-world-acceptanceminus-5-after-q3-takes-share-based-comp-hit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">World Acceptance -5% after Q3 takes share-based comp hit</a></h4><ul><li>World Acceptance (NASDAQ:<a href='https://seekingalpha.com/symbol/WRLD' title='World Acceptance Corporation'>WRLD</a>)<font color=\"red\"> slumps 5.0%</font> after posting fiscal Q3 EPS from continuing operations of 67 cents, down 44% from the comparable figure in the year-ago quarter.</li><li>The decrease was primarily due to additional share-based compensation expense of $6.2M ($4.9M after tax) associated with the previously disclosed long-term incentive program and director equity awards granted on October 15, 2018.</li><li>Furthermore, the company sees $13.3M of equity-based compensation expense for awards made under the LTIP and director equity awards in FY2019, $25.4M in FY2020, and $19.3M in FY2021.</li><li>Q3 total revenue of $137.6M rose from $125.7M a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428053-world-acceptance-eps-0_67\" target=\"_blank\">World Acceptance EPS of $0.67</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428230\" data-linked=\"World Acceptance -5% after Q3 takes share-based comp hit\" data-tweet=\"$WRLD - World Acceptance -5% after Q3 takes share-based comp hit https://seekingalpha.com/news/3428230-world-acceptanceminus-5-after-q3-takes-share-based-comp-hit?source=tweet\" data-url=\"https://seekingalpha.com/news/3428230-world-acceptanceminus-5-after-q3-takes-share-based-comp-hit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428228\" data-ts=\"1548953267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEL\" target=\"_blank\">CEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428228-cellcom-gets-new-tax-assessment-of-15_4m-for-2014\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellcom gets new tax assessment of $15.4M for 2014</a></h4><ul>   <li>In a <a href=\"https://seekingalpha.com/filing/4319959\" target=\"_blank\">filing</a>, Cellcom Israel (<a href=\"http://seekingalpha.com/symbol/CEL\" target=\"_blank\">CEL</a> <font color=\"green\">+4.5%</font>) notes it received a best-judgment assessment from the Israeli Tax Authority calling for additional tax tied to 2014.</li>    <li>If the company's claims are rejected, it will need to pay about 56M shekels in additional income tax, including interest and CPI differences.</li>    <li>That's about $15.4M.</li>    <li>\"The Company disputes the Israeli Tax Authority's position and believes, including based on consultation with its external advisors, that it has strong arguments, and intends to object the assessment,\" Cellcom says.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3428228\" data-linked=\"Cellcom gets new tax assessment of $15.4M for 2014\" data-tweet=\"$CEL - Cellcom gets new tax assessment of $15.4M for 2014 https://seekingalpha.com/news/3428228-cellcom-gets-new-tax-assessment-of-15_4m-for-2014?source=tweet\" data-url=\"https://seekingalpha.com/news/3428228-cellcom-gets-new-tax-assessment-of-15_4m-for-2014\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428220\" data-ts=\"1548952559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDC\" target=\"_blank\">MDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428220-m-d-c-holdingsplus-5-post-q4-revenue-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">M.D.C Holdings +5% post Q4 revenue beat</a></h4><div><ul><li>M.D.C Holdings (<a href='https://seekingalpha.com/symbol/MDC' title='M.D.C. Holdings, Inc.'>MDC</a> <font color=\"green\">+5.3%</font>) reported Q4 Home sales revenue increase of 21.9% Y/Y to $858.49M, and average selling price of homes delivered up 4% to $469k.</li><li>Q4 Gross margin from home sales <font color=\"green\">improved by 88 bps </font>to 18.1%.</li><li>SG&amp;A expenses increased 14.7% Y/Y to $93.37M and margin <font color=\"green\">improved by 70 bps</font> to 10.9%.</li><li>Dollar value of net new orders of $453.3M vs. $574.3M in 2017 fourth quarter.</li><li>Total homes completed or under construction 3,068 (+3% Y/Y) and Lots Owned and Optioned 23,187 (+20% Y/Y).</li><li>Backlog dollar value at December 31, 2018 down 11% Y/Y to $1.43B.</li><li>Net cash provided by operating activities for the quarter was $51.34M, compared to cash used $3.6M a year ago.</li><li>Company had total cash, cash equivalents and restricted cash of $470.14M, as of December 31, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3427341-m-d-c-holdings-declares-0_30-dividend-8-percent-stock-dividend\" target=\"_blank\">M.D.C. Holdings declares $0.30 dividend and 8% stock dividend</a> (Jan. 30)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3427959-m-d-c-holdings-misses-0_20-beats-revenue\" target=\"_blank\">M.D.C. Holdings misses by $0.20, beats on revenue</a> (Jan. 31)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3428220\" data-linked=\"M.D.C Holdings +5% post Q4 revenue beat\" data-tweet=\"$MDC - M.D.C Holdings +5% post Q4 revenue beat https://seekingalpha.com/news/3428220-m-d-c-holdingsplus-5-post-q4-revenue-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3428220-m-d-c-holdingsplus-5-post-q4-revenue-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428222\" data-ts=\"1548952505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHI\" target=\"_blank\">DHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428222-homebuilders-gain-after-new-home-sales-push-ahead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Homebuilders gain after new home sales push ahead</a></h4><ul><li>Homebuilders' stocks gain strongly after<a href=\"https://seekingalpha.com/news/3428174-new-home-sales-hit-nine-month-high-november\" target=\"_blank\"> new home sales</a> reached a nine-month high in November, and October's number was revised upward.</li><li>iShares Home Construction ETF (<a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a> <font color=\"green\">+2.8%</font>), while boasting a 12% return in the past month, is still down 22% over the past year.</li><li>Notable names on the move--D.R. Horton (<a href='https://seekingalpha.com/symbol/DHI' title='D. R. Horton Inc.'>DHI</a> <font color=\"green\">+3%</font>), KB Home (<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a> <font color=\"green\">+3.3%</font>), PulteGroup (<a href='https://seekingalpha.com/symbol/PHM' title='PulteGroup, Inc.'>PHM</a> <font color=\"green\">+3.2%</font>), Toll Brothers (<a href='https://seekingalpha.com/symbol/TOL' title='Toll Brothers Inc.'>TOL</a> <font color=\"green\">+3.2%</font>), Lennar (<a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a> <font color=\"green\">+2.8%</font>), and Beazer Homes (<a href='https://seekingalpha.com/symbol/BZH' title='Beazer Homes USA, Inc.'>BZH</a> <font color=\"green\">+3.9%</font>).</li><li>Other housing-related news that isn't moving the needle much:<a href=\"https://seekingalpha.com/pr/17397885-mortgage-rates-tick\" target=\"_blank\"> Mortgage rates</a> edge up, with the 30-year fixed-rate mortgage averaging 4.46% for the week ending Jan. 31, barely up from 4.45% in the previous week, according to Freddie Mac. Not much of needle-mover, here.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XHB' title='SPDR Homebuilders ETF'>XHB</a>, <a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a>, <a href='https://seekingalpha.com/symbol/DMO' title='Western Asset Mortgage Defined Opportunity Fund'>DMO</a>, <a href='https://seekingalpha.com/symbol/PKB' title='Invesco Dynamic Building & Construction Portfolio ETF'>PKB</a>, <a href='https://seekingalpha.com/symbol/TSI' title='TCW Strategic Income Fund'>TSI</a>, <a href='https://seekingalpha.com/symbol/PGZ' title='Principal Real Estate Inc Fund'>PGZ</a>, <a href='https://seekingalpha.com/symbol/JLS' title='Nuveen Mortgage Opportunity Term Fund'>JLS</a>, <a href='https://seekingalpha.com/symbol/NAIL' title='Direxion Daily Homebuilders & Supplies Bull 3x Shares ETF'>NAIL</a>, <a href='https://seekingalpha.com/symbol/CMBS' title='iShares CMBS ETF'>CMBS</a>, <a href='https://seekingalpha.com/symbol/FMY' title='First Trust Mortgage Income Fund'>FMY</a>, <a href='https://seekingalpha.com/symbol/HOML' title='ETRACS Monthly Reset 2xLeveraged ISE Exclusively Homebuilders ETN'>HOML</a>, <a href='https://seekingalpha.com/symbol/JMT' title='Nuveen Mortgage Opportunity Term Fund 2'>JMT</a>, <a href='https://seekingalpha.com/symbol/LMBS' title='First Trust Low Duration Mortgage Opportunities ETF'>LMBS</a>, <a href='https://seekingalpha.com/symbol/MBSD' title='FlexShares Disciplined Duration MBS Index ETF'>MBSD</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3428222\" data-linked=\"Homebuilders gain after new home sales push ahead\" data-tweet=\"$DHI $ITB $DHI - Homebuilders gain after new home sales push ahead https://seekingalpha.com/news/3428222-homebuilders-gain-after-new-home-sales-push-ahead?source=tweet\" data-url=\"https://seekingalpha.com/news/3428222-homebuilders-gain-after-new-home-sales-push-ahead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428221\" data-ts=\"1548951982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428221-u-s-steelminus-3-european-sales-weigh-profit-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel -3% as European sales weigh profit outlook</a></h4><ul><li>U.S. Steel (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='red'>-3.2%</font>) is sharply lower after <a href=\"https://seekingalpha.com/news/3427873-u-s-steel-minus-6-percent-q4-miss-downside-q1-ebitda-guidance\" target=\"_blank\">forecasting lower than expected profit</a> as prices fall and costs rise faster than expected in Europe.</li><li>U.S. Steel's European business \u201cis <a href=\"https://www.bloomberg.com/news/articles/2019-01-31/u-s-steel-drops-as-quarterly-sales-profit-trail-estimates\" target=\"_blank\">under a lot of pressure</a>, and that\u2019s a big change for us,\u201d the company said in its earnings conference call, an outlook that comes on top of U.S.-China trade tensions and slowing global economic growth that have fed concerns over demand prospects.</li><li>The main takeaway from U.S. Steel\u2019s (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='red'>-3.2%</font>) forecast \"is a much weaker than expected guide for Q1\" 2019, Goldman Sachs analyst Matthew Korn writes. \"Partial details provided for the FY 2019 outlook indicate fewer shipments and higher capex than our current forecasts.\"</li><li>Goldman maintains its neutral rating on the shares while cutting its price target to $27 from $32.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428221\" data-linked=\"U.S. Steel -3% as European sales weigh profit outlook\" data-tweet=\"$X - U.S. Steel -3% as European sales weigh profit outlook https://seekingalpha.com/news/3428221-u-s-steelminus-3-european-sales-weigh-profit-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3428221-u-s-steelminus-3-european-sales-weigh-profit-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428218\" data-ts=\"1548951736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPOT\" target=\"_blank\">SPOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428218-variety-spotify-postpones-india-launch-talks-continue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Variety: Spotify postpones India launch as talks continue</a></h4><ul>   <li>Spotify (<a href=\"http://seekingalpha.com/symbol/SPOT\" target=\"_blank\">SPOT</a> <font color=\"green\">+1.9%</font>) has <a href=\"https://variety.com/2019/digital/news/spotifys-india-launch-postponed-1203124575/\" target=\"_blank\">postponed its launch in India</a>, <i>Variety</i> reports, after rumors of a Jan. 31 <a href=\"https://seekingalpha.com/news/3423123-variety-spotify-india-launch-come-month\" target=\"_blank\">Mumbai launch party</a> failed to pan out and the company this month was reportedly still locking down deals in the country with major-label giants Sony, Universal and Warner.</li>    <li>The launch was postponed just in the past few days, according to the report, and now will happen in February or March.</li>    <li>While Spotify could conceivably move forward without solid deals with the major labels, other deals are vital to expand into various regional music markets, including that in five languages.</li>    <li>A sticking point in the launch may be a free trial launch period that's expected to be longer than the 30 days offered in other markets, but feature a dramatically lower royalty than local services are paying.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428218\" data-linked=\"Variety: Spotify postpones India launch as talks continue\" data-tweet=\"$SPOT - Variety: Spotify postpones India launch as talks continue https://seekingalpha.com/news/3428218-variety-spotify-postpones-india-launch-talks-continue?source=tweet\" data-url=\"https://seekingalpha.com/news/3428218-variety-spotify-postpones-india-launch-talks-continue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428217\" data-ts=\"1548951728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COTY\" target=\"_blank\">COTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428217-cotyplus-6-on-bill-miller-mention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coty +6% on Bill Miller mention</a></h4><ul> <li>Coty (NYSE:<a href='https://seekingalpha.com/symbol/COTY' title='Coty Inc.'>COTY</a>) runs up a <font color=\"green\">6% gain</font> after portfolio manager Bill Miller singles out the beauty products seller as undervalued.</li> <li>Miller thinks shares of Coty have bottomed out after a multi-year slide.</li> <li>Also within the sector, Miller's positive comments on Avon Products sent the Coty rival up 27%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428214-avon-products-plus-26-percent-bill-miller-calls-upside\" target=\"_blank\">Avon Products +26% after Bill Miller calls out upside</a> (Jan. 31)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428217\" data-linked=\"Coty +6% on Bill Miller mention\" data-tweet=\"$COTY - Coty +6% on Bill Miller mention https://seekingalpha.com/news/3428217-cotyplus-6-on-bill-miller-mention?source=tweet\" data-url=\"https://seekingalpha.com/news/3428217-cotyplus-6-on-bill-miller-mention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428216\" data-ts=\"1548951587\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428216-facebook-leads-surging-nasdaq-while-banks-stumble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook leads surging Nasdaq, while banks stumble</a></h4><ul><li>Facebook is shooting <font color=\"green\">higher by 13%</font> following a big earnings beat. That's helping the Nasdaq (NASDAQ:<a href='https://seekingalpha.com/symbol/QQQ' title='Invesco QQQ ETF'>QQQ</a>) to a <font color=\"green\">1.25% advance</font> vs. a <font color=\"green\">0.6% gain</font> for the S&amp;P 500 and a <font color=\"red\">modest decline</font> in the Dow.</li><li>Very much not participating in today's rally are the financials (<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color=\"red\">-0.8%</font>), with TBTF players like Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color=\"red\">-3%</font>), Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color=\"red\">-1.7%</font>), and JPMorgan (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color=\"red\">-1.4%</font>) leading declines one day after the Fed hinted the next move in policy might more likely be an ease, rather than tightening.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428216\" data-linked=\"Facebook leads surging Nasdaq, while banks stumble\" data-tweet=\"$BAC $QQQ $XLF - Facebook leads surging Nasdaq, while banks stumble https://seekingalpha.com/news/3428216-facebook-leads-surging-nasdaq-while-banks-stumble?source=tweet\" data-url=\"https://seekingalpha.com/news/3428216-facebook-leads-surging-nasdaq-while-banks-stumble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428215\" data-ts=\"1548951561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTX\" target=\"_blank\">CYTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428215-cytori-up-12-on-cell-therapy-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cytori up 12% on cell therapy data</a></h4><ul><li>Thinly traded nano cap Cytori Therapeutics (<a href='https://seekingalpha.com/symbol/CYTX' title='Cytori Therapeutics Inc'>CYTX</a> <font color=\"green\">+12.1%</font>) is up on an 11x surge in volume in reaction to the publication in the journal <em>Gastroenterology </em>of <a href=\"https://seekingalpha.com/pr/17397551-cytori-cell-therapy-clinical-trial-results-crohn-s-disease\" target=\"_blank\">results </a>from an investigator-initiated pilot study in France assessing Cytori Cell Therapy for the treatment of perianal fistula in Crohn's disease patients.</li><li>80% (n=8/10) of treated patients responded. 60% (n=6/10) were considered to be in combined remission with no evidence of leakage.</li><li>76% of treated external fistula openings showed complete re-epithelialization or absence of drainage at week 48.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428215\" data-linked=\"Cytori up 12% on cell therapy data\" data-tweet=\"$CYTX $PSTV - Cytori up 12% on cell therapy data https://seekingalpha.com/news/3428215-cytori-up-12-on-cell-therapy-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3428215-cytori-up-12-on-cell-therapy-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428214\" data-ts=\"1548951456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVP\" target=\"_blank\">AVP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428214-avon-productsplus-26-after-bill-miller-calls-out-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avon Products +26% after Bill Miller calls out upside</a></h4><ul> <li>Avon Products (<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='green'>+25.7%</font>) jumps after portfolio manager Bill Miller tells <a href=\"https://www.cnbc.com/2019/01/31/avon-jumps-about-20percent-on-positive-comments-from-value-investor-bill-miller.html\" target=\"_blank\">CNBC</a> that the stock is one of the most interesting that he's seen lately.</li> <li>\"We think it's a company that could be a 10 bagger in the next three to five years,\" stated Miller.</li> <li>He sees the proper strategy finally in place at Avon.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428214\" data-linked=\"Avon Products +26% after Bill Miller calls out upside\" data-tweet=\"$AVP - Avon Products +26% after Bill Miller calls out upside https://seekingalpha.com/news/3428214-avon-productsplus-26-after-bill-miller-calls-out-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3428214-avon-productsplus-26-after-bill-miller-calls-out-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428213\" data-ts=\"1548951346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428213-german-court-tosses-qualcomm-patents\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">German court tosses Qualcomm patents</a></h4><ul><li>A regional German court <a href=\"https://www.wsj.com/articles/german-court-throws-out-four-qualcomm-patent-suits-against-apple-11548948009\" target=\"_blank\">dismisses </a>four Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) patent lawsuits against Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) rejecting claims of Apple's infringement with some iPhone search capabilities.</li><li>The court has yet to decide on another four search-related patents.</li><li>The decision comes from the same court that gave Qualcomm a <a href=\"https://seekingalpha.com/news/3418483-apple-faces-iphone-ban-germany-update\" target=\"_blank\">hardware patent victory</a> in December, which included an injunction banning the sale of some iPhones.</li><li>QCOM is <font color=\"red\">down 1.6%</font> to $49.38. Apple is <font color=\"green\">up 1.8%</font> to $168.18.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428213\" data-linked=\"German court tosses Qualcomm patents\" data-tweet=\"$QCOM $QCOM $AAPL - German court tosses Qualcomm patents https://seekingalpha.com/news/3428213-german-court-tosses-qualcomm-patents?source=tweet\" data-url=\"https://seekingalpha.com/news/3428213-german-court-tosses-qualcomm-patents\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428210\" data-ts=\"1548950755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TUES\" target=\"_blank\">TUES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428210-on-tuesday-mornings-q2-mixed-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Tuesday Morning&#39;s Q2 mixed results</a></h4><ul><li>Tuesday Morning (<a href='https://seekingalpha.com/symbol/TUES' title='Tuesday Morning Corp.'>TUES</a> <font color='green'>+16.1%</font>) reports comparable store sales increased 1.9% in <a href=\"https://seekingalpha.com/pr/17397426-tuesday-morning-corporation-announces-second-quarter-fiscal-2019-results\" target=\"_blank\">Q2</a>, comprised of a 1.1% increase in customer transactions along with a 0.8% increase in average ticket.</li><li>Gross margin rate improved 280 bps to 34.5%.</li><li>SG$A expense rate +50 bps to 29.7%.</li><li>Store count -4 Y/Y at 720.</li><li><strong>FY2019 Guidance</strong>: Comparable store sales: +2% to +3%; Net loss: ~$8M to $12M; EBITDA: ~$17M to $21M; Adjusted EBITDA: ~$21M to $25M; Net capital expenditure: ~$12M to $15M; New stores: 10 to 12.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428083-tuesday-morning-beats-0_06-misses-revenue\" target=\"_blank\">Tuesday Morning beats by $0.06, misses on revenue</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428210\" data-linked=\"More on Tuesday Morning&#39;s Q2 mixed results\" data-tweet=\"$TUES - More on Tuesday Morning&#39;s Q2 mixed results https://seekingalpha.com/news/3428210-on-tuesday-mornings-q2-mixed-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3428210-on-tuesday-mornings-q2-mixed-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428208\" data-ts=\"1548950571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBIO\" target=\"_blank\">FBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428208-fortress-biotech-leads-healthcare-gainers-aveo-pharmaceuticals-and-innoviva-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortress Biotech leads healthcare gainers; AVEO Pharmaceuticals and Innoviva among losers</a></h4><ul><li><b>Gainers: </b>Fortress Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a>) <font color=\"green\">+42%</font>. MeiraGTx Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MGTX' title='MeiraGTx Holdings plc'>MGTX</a>) <font color=\"green\">+29%</font>. China SXT Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SXTC' title='China SXT Pharmaceuticals, Inc.'>SXTC</a>) <font color=\"green\">+23%</font>. Prana Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/PRAN' title='Prana Biotechnology Ltd'>PRAN</a>) <font color=\"green\">+13%</font>. Novus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NVUS' title='Novus Therapeutics'>NVUS</a>) <font color=\"green\">+13%</font>.</li><li><b>Losers: </b>AVEO Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a>) <font color=\"red\">-57%</font>. Co-Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics'>CODX</a>) <font color=\"red\">-36%</font>. Innoviva (NASDAQ:<a href='https://seekingalpha.com/symbol/INVA' title='Innoviva, Inc.'>INVA</a>) <font color=\"red\">-11%</font>. Aquestive Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AQST' title='Aquestive Therapeutics'>AQST</a>) <font color=\"red\">-10%</font>. Eyenovia (NASDAQ:<a href='https://seekingalpha.com/symbol/EYEN' title='Eyenovia, Inc.'>EYEN</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428208\" data-linked=\"Fortress Biotech leads healthcare gainers; AVEO Pharmaceuticals and Innoviva among losers\" data-tweet=\"$FBIO $FBIO $MGTX - Fortress Biotech leads healthcare gainers; AVEO Pharmaceuticals and Innoviva among losers https://seekingalpha.com/news/3428208-fortress-biotech-leads-healthcare-gainers-aveo-pharmaceuticals-and-innoviva-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3428208-fortress-biotech-leads-healthcare-gainers-aveo-pharmaceuticals-and-innoviva-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428206\" data-ts=\"1548950485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INNV\" target=\"_blank\">INNV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428206-innovus-launches-xyralid-in-canada-shares-up-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Innovus launches Xyralid in Canada; shares up 8%</a></h4><ul><li>Innovus Pharmaceuticals (<a href='https://seekingalpha.com/symbol/INNV' title='Innovus Pharmaceuticals, Inc.'>OTCQB:INNV</a> <font color=\"green\">+7.8%</font>) is up on below-average volume on the heels of the Canadian <a href=\"https://seekingalpha.com/pr/17397145-innovus-pharma-announces-approval-launch-otc-hemorrhoid-xyralid-suppositories-canada\" target=\"_blank\">launch </a>of its Xyralid Suppositories for hemorrhoids.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428206\" data-linked=\"Innovus launches Xyralid in Canada; shares up 8%\" data-tweet=\"$INNV - Innovus launches Xyralid in Canada; shares up 8% https://seekingalpha.com/news/3428206-innovus-launches-xyralid-in-canada-shares-up-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3428206-innovus-launches-xyralid-in-canada-shares-up-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428201\" data-ts=\"1548950124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTDOY\" target=\"_blank\">NTDOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428201-nintendominus-4_5-blowout-quarter-holds-downbeat-switch-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nintendo -4.5% as blowout quarter holds downbeat Switch forecast</a></h4><ul>   <li>Nintendo (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>) is <font color=\"red\">off 4.5%</font> in U.S. trading after a <a href=\"https://seekingalpha.com/news/3427970-nintendo-reports-9m-results\" target=\"_blank\">solid quarter</a> boosted by holiday sales of its Switch console also contained heavy cuts to its full-year sales forecast.</li>    <li>It now expects to sell 17M of the units vs. a previous 20M for the year ending in March.</li>    <li>The company sold 9.4M Switch consoles for the quarter, helping boost revenues 26% and bringing cumulative unit sales to 32.3M.</li>    <li>That's led to an entrenched base for heavier software sales than on past Nintendo platforms. For the nine-month period, three Switch titles became \"major hits with record sales, which helped invigorate the platform\": <i>Super Mario Party</i> (5.3M units), <i>Pokemon: Let's Go, Pikachu!</i> and <i>Pokemon: Let's Go, Eevee!</i> (10M units); and <i>Super Smash Bros. Ultimate</i> (12.08M units).</li>    <li>And despite the cut to console forecasts, it's raised its Switch software forecast to 110M units from a previous 100M.</li>    <li>Operating profit in the quarter was ¥158.6B (about $1.46B), easily above consensus and its highest in nine years.</li>    <li><a href=\"https://www.nintendo.co.jp/ir/pdf/2019/190131e.pdf\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3428201\" data-linked=\"Nintendo -4.5% as blowout quarter holds downbeat Switch forecast\" data-tweet=\"$NTDOY $NTDOF - Nintendo -4.5% as blowout quarter holds downbeat Switch forecast https://seekingalpha.com/news/3428201-nintendominus-4_5-blowout-quarter-holds-downbeat-switch-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3428201-nintendominus-4_5-blowout-quarter-holds-downbeat-switch-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428199\" data-ts=\"1548950099\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TUES\" target=\"_blank\">TUES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428199-tuesday-morning-rallies-18_6-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tuesday Morning rallies 18.6% post Q2 results</a></h4><ul><li>Tuesday Morning (<a href='https://seekingalpha.com/symbol/TUES' title='Tuesday Morning Corp.'>TUES</a> <font color=\"green\">+18.6%</font>) reports <a href=\"https://seekingalpha.com/pr/17397426-tuesday-morning-corporation-announces-second-quarter-fiscal-2019-results\" target=\"_blank\">Q2</a> revenue growth of 1.4% Y/Y to $338.42M, comparable store sales increased 1.9%.</li><li>Gross margin <font color=\"green\">increased ~280 bps</font> to 34.5%.</li><li>Operating income increased 96% Y/Y to $16.3M, net income increased 84% Y/Y to $16M, and adj. EBITDA increased 47%  Y/Y to $24.4M.</li><li>As a percentage of net sales, SG&amp;A was 29.7%, deleveraging ~50 bps.</li><li>During Q2, 3 stores were relocated, 2 stores were opened, and 1 store was expanded, for an ending store count of 720.</li><li>The Company ended fiscal 2018 with $6.1M in cash and equivalents; had $5M outstanding under its line of credit with availability on the line of $93.7 million &amp; inventories were $226.9M.</li><li><b>Revised 2019 Outlook:</b> Comparable store sales for fiscal 2019 to increase 2-3%; Net Loss ~$8-12M, EBITDA ~$17-21M, expects Adj. EBITDA ~$21-25M, plans to open 10-12 new stores, relocate 15-20 stores, expand 1 store and close 20-25 stores; Net capex ~$12-15M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428083-tuesday-morning-beats-0_06-misses-revenue\" target=\"_blank\">Tuesday Morning beats by $0.06, misses on revenue</a> (Jan. 31 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428199\" data-linked=\"Tuesday Morning rallies 18.6% post Q2 results\" data-tweet=\"$TUES - Tuesday Morning rallies 18.6% post Q2 results https://seekingalpha.com/news/3428199-tuesday-morning-rallies-18_6-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3428199-tuesday-morning-rallies-18_6-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428192\" data-ts=\"1548949476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFF\" target=\"_blank\">GFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428192-griffon-jumpsplus-13-post-q1-results-and-improved-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Griffon jumps +13% post Q1 results and improved margins</a></h4><ul><li>Griffon (<a href='https://seekingalpha.com/symbol/GFF' title='Griffon Corporation'>GFF</a> <font color=\"green\">+13.5%</font>) reported Q1 revenue growth of 16.7% Y/Y to $510.52M, with Home &amp; Building Products +19% and Defense Electronics +7%.</li><li>Q1 gross margin<font color=\"green\"> improved by 40 bps</font> to 28% and operating margin <font color=\"green\">improved by 250 bps</font> to 5.7%.</li><li>Home &amp; Building Products revenue $439.77M (+18.5% Y/Y), with AMES $216.47M (flat) and CBP $223.29M (+44.8% Y/Y).</li><li>Segment Adj. EBITDA margin: Home &amp; Building Products <font color=\"green\">improved by 116 bps</font> to 11.8% and Defense Electronics <font color=\"green\">improved by 43 bps</font> to 6.7%.</li><li>SG&amp;A expenses increased by 6.7% Y/Y to $113.75M and margin <font color=\"green\">declined by 210 bps</font> to 22.3%.</li><li>Contract backlog was $367M at December 31, 2018.</li><li>Company had cash and equivalents of $81.75M and total debt outstanding of $1,155M, as of December 31, 2018.</li><li>During the quarter company purchased 29,300 shares of common stock under repurchase programs, for $9.91 per share. At December 31, 2018, $58M remained under existing Board authorizations.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428082-griffon-declares-0_0725-dividend\" target=\"_blank\">Griffon declares $0.0725 dividend</a> (Jan. 31)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428094-griffon-beats-0_14-misses-revenue\" target=\"_blank\">Griffon beats by $0.14, misses on revenue</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428192\" data-linked=\"Griffon jumps +13% post Q1 results and improved margins\" data-tweet=\"$GFF - Griffon jumps +13% post Q1 results and improved margins https://seekingalpha.com/news/3428192-griffon-jumpsplus-13-post-q1-results-and-improved-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3428192-griffon-jumpsplus-13-post-q1-results-and-improved-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428195\" data-ts=\"1548949426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHN\" target=\"_blank\">ACHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428195-achillion-commences-early-stage-study-of-next-gen-factor-d-inhibitor-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achillion commences early-stage study of next-gen factor D inhibitor; shares up 2%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17397123-achillion-announces-first-dosing-phase-1-multiple-ascending-dose-study-achminus-5228-next\" target=\"_blank\">Dosing is underway</a> in a 38-subject Phase 1 multiple ascending dose clinical trial evaluating Achillion Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color=\"green\">+2.3%</font>) ACH-5228, one of its next-generation oral small molecule factor D inhibitors, in healthy volunteers. Results should be available in Q3.</li><li>The company says the completed single ascending dose study demonstrated ACH-5228's enhanced potency and improved pharmacokinetics compared to first-generation factor D inhibitor ACH-4471.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428195\" data-linked=\"Achillion commences early-stage study of next-gen factor D inhibitor; shares up 2%\" data-tweet=\"$ACHN - Achillion commences early-stage study of next-gen factor D inhibitor; shares up 2% https://seekingalpha.com/news/3428195-achillion-commences-early-stage-study-of-next-gen-factor-d-inhibitor-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3428195-achillion-commences-early-stage-study-of-next-gen-factor-d-inhibitor-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428194\" data-ts=\"1548949193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPD\" target=\"_blank\">EPD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428194-enterprise-products-on-rise-after-q4-results-ngl-pipeline-conversion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enterprise Products on the rise after Q4 results, NGL pipeline conversion</a></h4><ul><li>Enterprise Products Partners (<a href='https://seekingalpha.com/symbol/EPD' title='Enterprise Products Partners L.P'>EPD</a> <font color=\"green\">+1.6%</font>) moves higher after reporting mixed <a href=\"https://seekingalpha.com/news/3427965-enterprise-products-partners-beats-0_08-misses-revenue\" target=\"_blank\">Q4 results</a> and announcing a <a href=\"https://seekingalpha.com/pr/17397107-enterprise-announces-2-billion-unit-buyback-program-provides-2019-distribution-guidance\" target=\"_blank\">$2B unit buyback program</a>.</li><li>EPD says Q4 gross operating margin rose 41% Y/Y to a record $2.1B from $1.5B in the year-ago quarter, led by a record $644M gross operating margin from       the crude oil pipelines and services segment.</li><li>For 2019, EPD anticipates capital spending of $3.5B-$3.9B, including growth capex of $3.1B-$3.5, and expect to receive $645M of cash contributions from business partners.</li><li>EPD says it is readying the conversion of its Seminole natural gas liquids pipeline in the Permian Basin to move 200K bbl/day of crude, with initial service starting in February.</li><li>EPD also plans to continue to recommend to       its board a $0.0025/unit per quarter increase to its distribution       rate, resulting in a 2.3% increase in       distributions paid with respect to 2019 to $1.765/unit.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428194\" data-linked=\"Enterprise Products on the rise after Q4 results, NGL pipeline conversion\" data-tweet=\"$EPD - Enterprise Products on the rise after Q4 results, NGL pipeline conversion https://seekingalpha.com/news/3428194-enterprise-products-on-rise-after-q4-results-ngl-pipeline-conversion?source=tweet\" data-url=\"https://seekingalpha.com/news/3428194-enterprise-products-on-rise-after-q4-results-ngl-pipeline-conversion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428193\" data-ts=\"1548949187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BC\" target=\"_blank\">BC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428193-post-earnings-decline-for-brunswick\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings decline for Brunswick</a></h4><ul> <li>Brunswick (NYSE:<a href='https://seekingalpha.com/symbol/BC' title='Brunswick Corporation'>BC</a>) is <font color=\"red\">down 2.25%</font> after the company issues profit guidance below the expectations of analysts.</li> <li>The company expects full-year EPS of $4.80 to $5.05 vs. $5.21 consensus. Top-line performance is seen benefiting from a steady global marine market and the ingoing benefits from customer migration to higher horsepower engines and boats with increased technology and content. Operating expenses are anticipated to decline slightly as a percentage of sales basis and operating earnings for the marine business are expected to grow at a high-teens percentage.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3428193\" data-linked=\"Post-earnings decline for Brunswick\" data-tweet=\"$BC - Post-earnings decline for Brunswick https://seekingalpha.com/news/3428193-post-earnings-decline-for-brunswick?source=tweet\" data-url=\"https://seekingalpha.com/news/3428193-post-earnings-decline-for-brunswick\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428183\" data-ts=\"1548948728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVUS\" target=\"_blank\">NVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428183-novus-up-15-on-advancement-of-op0201\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novus up 15% on advancement of OP0201</a></h4><ul><li>Thinly traded nano cap Novus Therapeutics (<a href='https://seekingalpha.com/symbol/NVUS' title='Novus Therapeutics'>NVUS</a> <font color=\"green\">+14.9%</font>) is up on average volume following its <a href=\"https://seekingalpha.com/pr/17395747-novus-therapeutics-advances-op0201-development-program-across-several-clinical-trials\" target=\"_blank\">updates</a> on clinical trials supporting lead drug OP0201.</li><li><strong>Phase 1 trials</strong>: first dose cohort completed in adult safety and tolerability study (C-002). Screening for second higher dose cohort underway. Initial screening underway in single-dose safety and pharmacodynamics study (C-001). Data from both trials should be available in Q2. Enrollment completed in single-dose safety and preliminary efficacy study (C-004) in adults with acute otitis media (ear infection) with data expected later this quarter.</li><li>A Phase 2a study, C-006, in infants and children with acute otitis media has been added. Enrollment will commence in the coming weeks with topline results expected in H2.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428183\" data-linked=\"Novus up 15% on advancement of OP0201\" data-tweet=\"$NVUS - Novus up 15% on advancement of OP0201 https://seekingalpha.com/news/3428183-novus-up-15-on-advancement-of-op0201?source=tweet\" data-url=\"https://seekingalpha.com/news/3428183-novus-up-15-on-advancement-of-op0201\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428189\" data-ts=\"1548948639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428189-natural-gas-inventory-draw-slightly-less-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory draw slightly less than consensus</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>-173 Bcf</strong> vs. -189 Bcf consensus, -163 Bcf last week.</li><li>Futures <font color=\"green\">+0.07%</font> to $2.856.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3428189\" data-linked=\"Natural gas inventory draw slightly less than consensus\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory draw slightly less than consensus https://seekingalpha.com/news/3428189-natural-gas-inventory-draw-slightly-less-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3428189-natural-gas-inventory-draw-slightly-less-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428188\" data-ts=\"1548948431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UN\" target=\"_blank\">UN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428188-latin-america-woes-continue-for-unilever\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Latin America woes continue for Unilever</a></h4><ul> <li>Unilever (<a href='https://seekingalpha.com/symbol/UN' title='Unilever NV'>UN</a>, <a href='https://seekingalpha.com/symbol/UL' title='Unilever Plc'>UL</a>) is <font color=\"red\">down 1%</font> after the slowdown in Latin America continues to drag on the company's bottom line.</li> <li>\"Looking forward we have indicated that we expect growth to be more in the 3 to 4 percent range, which is the lower half of our ongoing guidance and it basically reflects some of the volatility in emerging markets, notably in Latin America,\" new Unilever CEO Alan Jope tells <a href=\"https://www.cnbc.com/2019/01/31/unilever-q4-2018-results.html\" target=\"_blank\">CNBC</a>.</li> <li>Unilever execs have also been pointing to cost pressures in areas such as packaging to transport as another reason that it's behind some of the ambitious profit targets laid out.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3427940-unilever-reports-fy-results\" target=\"_blank\">Unilever reports FY results</a> (Jan. 31)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428188\" data-linked=\"Latin America woes continue for Unilever\" data-tweet=\"$UN $UN $UL - Latin America woes continue for Unilever https://seekingalpha.com/news/3428188-latin-america-woes-continue-for-unilever?source=tweet\" data-url=\"https://seekingalpha.com/news/3428188-latin-america-woes-continue-for-unilever\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428186\" data-ts=\"1548947794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCD\" target=\"_blank\">MCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428186-baml-sees-mcdonalds-well-positioned-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML sees McDonald&#39;s well positioned to outperform</a></h4><ul> <li>Bank of America Merrill Lynch keeps a Buy rating in place on McDonald's (<a href='https://seekingalpha.com/symbol/MCD' title='McDonald&#39;s Corporation'>MCD</a> <font color='red'>-1.7%</font>) after factoring in the company's Q4 report and guidance update.</li> <li>While the firm reels in its FY19 EPS on MCD to $8.20 from $8.35 due to the expectation for smaller refranchising gains and a reduced franchise margin forecast, the long-term outlook is positive.</li> <li>\"We see unit growth ticking up from 1.6% to 2%-2.5% over the next 18 months coupled with continued 4% global comps that should drive 5%-6% EBITDA growth,\" reads the BAML note.</li> <li>\"We think MCD is well positioned given high sales volumes, strong store level cash flow and reinvestments back into the business that should afford it the opportunity to kill off lower ROI competitors if its franchisees stay aggressive on value.\"</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3428186\" data-linked=\"BAML sees McDonald&#39;s well positioned to outperform\" data-tweet=\"$MCD - BAML sees McDonald&#39;s well positioned to outperform https://seekingalpha.com/news/3428186-baml-sees-mcdonalds-well-positioned-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3428186-baml-sees-mcdonalds-well-positioned-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428182\" data-ts=\"1548947252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALGT\" target=\"_blank\">ALGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428182-allegiant-travelplus-5-on-strong-profit-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegiant Travel +5% on strong profit forecast</a></h4><ul> <li>Allegiant Travel (NASDAQ:<a href='https://seekingalpha.com/symbol/ALGT' title='Allegiant Travel Company'>ALGT</a>) runs up a <font color=\"green\">5.4% gain</font> after topping estimates on both lines of its Q4 report.</li> <li>Investors also have their eyes on Allegiant's strong profit guidance. The company says it expects full-year EPS of $13.25 to $14.75 vs. $12.85 consensus.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3427748-allegiant-travel-company-beats-0_06-beats-revenue\" target=\"_blank\">Allegiant Travel Company beats by $0.06, beats on revenue</a> (Jan. 30)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428182\" data-linked=\"Allegiant Travel +5% on strong profit forecast\" data-tweet=\"$ALGT - Allegiant Travel +5% on strong profit forecast https://seekingalpha.com/news/3428182-allegiant-travelplus-5-on-strong-profit-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3428182-allegiant-travelplus-5-on-strong-profit-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428179\" data-ts=\"1548947074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHTR\" target=\"_blank\">CHTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428179-charterplus-14-internet-growth-continues-to-drive-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Charter +14% as Internet growth continues to drive gains</a></h4><ul>   <li>Charter Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a>) is <font color=\"green\">up 14.4%</font> and topping four-month highs as continued broadband customer growth offset more video declines and boosted revenue to beat expectations.</li>    <li>Revenues rose 5.9% overall; residential was up 3.9%, commercial up 4.5%. Ad revenue grew 34.1%.</li>    <li>Net income dropped to $296M from $9.6B due to a GAAP tax benefit from reduction in deferred tax liability, from federal tax reform.</li>    <li>Total residential/SMB customer relationships rose by 248,000 vs. the prior year's gain of 209,000. Residential Internet net adds were 289,000, above expectations for 275,000, while video declines (of 36,000) and phone declines (of 83,000) were worse than expected.</li>    <li>Revenue breakout: Video, $4.36B (up 3.4%); Internet, $3.9B (up 7.1%); Voice, $515M (down 12.3%); Small and medium business, $928M (up 3.6%); Enterprise, $647M (up 5.7%); Advertising sales, $562M (up 34.1%); Mobile, $89M (new).</li>    <li>Cash from operations was $3.17B -- down from $3.3B due to smaller working capital benefit and higher cash interest -- and free cash flow came in a little light at $885M.</li>    <li>Principal debt at Dec. 31 was $72B, and credit facilities provided about $2.8B in liquidity in excess of $551M in cash.</li>    <li><a href=\"https://seekingalpha.com/article/4236980-charter-communications-inc-2018-q4-results-earnings-call-slides\" target=\"_blank\">Earnings call slides</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3428025-charter-communications-misses-0_15-beats-revenue\" target=\"_blank\">Charter Communications misses by $0.15, beats on revenue</a> (Jan. 31 2019)</li>   <li><a href=\"https://seekingalpha.com/pr/17397242-charter-announces-fourth-quarter-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3428179\" data-linked=\"Charter +14% as Internet growth continues to drive gains\" data-tweet=\"$CHTR - Charter +14% as Internet growth continues to drive gains https://seekingalpha.com/news/3428179-charterplus-14-internet-growth-continues-to-drive-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3428179-charterplus-14-internet-growth-continues-to-drive-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428178\" data-ts=\"1548947022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRAN\" target=\"_blank\">PRAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428178-prana-bio-up-23-on-new-orphan-drug-status-for-pbt434\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prana Bio up 23% on new Orphan Drug status for PBT434</a></h4><ul><li>Thinly traded nano cap Prana Biotechnology (<a href='https://seekingalpha.com/symbol/PRAN' title='Prana Biotechnology Ltd'>PRAN</a> <font color=\"green\">+22.5%</font>) is up double normal volume on the heels of <a href=\"https://seekingalpha.com/pr/17397722-prana-receives-first-orphan-drug-designation-fda-treatment-multiple-system-atrophy\" target=\"_blank\">U.S. Orphan Drug status</a> for top candidate PBT434 for the treatment of <a href=\"https://www.mayoclinic.org/diseases-conditions/multiple-system-atrophy/symptoms-causes/syc-20356153\" target=\"_blank\">multiple system atrophy</a> &#40;MSA&#41;, a rare progressive neurological disorder akin to Parkinson's disease that affects the body's involuntary functions such as blood pressure and breathing.</li><li>PBT434 belongs to a class of molecules called quinazolinones which block the accumulation and aggregation of a protein called <a href=\"https://www.michaeljfox.org/understanding-parkinsons/living-with-pd/topic.php?alpha-synuclein\" target=\"_blank\">alpha-synuclein</a> which is associated with Parkinson's and Lewy body dementia.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428178\" data-linked=\"Prana Bio up 23% on new Orphan Drug status for PBT434\" data-tweet=\"$PRAN $ATHE - Prana Bio up 23% on new Orphan Drug status for PBT434 https://seekingalpha.com/news/3428178-prana-bio-up-23-on-new-orphan-drug-status-for-pbt434?source=tweet\" data-url=\"https://seekingalpha.com/news/3428178-prana-bio-up-23-on-new-orphan-drug-status-for-pbt434\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428175\" data-ts=\"1548946924\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TJX\" target=\"_blank\">TJX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428175-telsey-bullish-on-tjx-companies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telsey bullish on TJX Companies</a></h4><ul> <li>Telsey Advisory Group upgrades TJX Companies (<a href='https://seekingalpha.com/symbol/TJX' title='TJX Companies Inc.'>TJX</a> <font color='green'>+0.1%</font>) to an Outperform rating after having the retailer set at Market Perform.</li> <li>TJX is seen gaining more market share as its business model evolves.</li> <li>Telsey takes its price target on TJX to $56 from $51. The 52-week high for the stock is $56.64.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428175\" data-linked=\"Telsey bullish on TJX Companies\" data-tweet=\"$TJX - Telsey bullish on TJX Companies https://seekingalpha.com/news/3428175-telsey-bullish-on-tjx-companies?source=tweet\" data-url=\"https://seekingalpha.com/news/3428175-telsey-bullish-on-tjx-companies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428171\" data-ts=\"1548946349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTGN\" target=\"_blank\">VTGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428171-vistagen-up-5-on-preclinical-avminus-101-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VistaGen up 5% on preclinical AV-101 data</a></h4><ul><li>Thinly traded nano cap VistaGen Therapeutics (<a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color=\"green\">+5.3%</font>) is up on double normal volume following its <a href=\"https://seekingalpha.com/pr/17397560-avminus-101-stimulates-formation-new-brain-cells-nonclinical-studies\" target=\"_blank\">announcement </a>of encouraging preclinical data on lead candidate AV-101 (4-chlorokynurenine), in development for major depressive disorder and neuropathic pain.</li><li>The results showed that AV-101 promotes the formation of new nerve cells in the hippocampus, the part of the brain that controls emotion, memory and spatial navigation.</li><li>CEO Shawn Singh says new cell formation in the hippocampus provides protection against stress-related psychiatric disorders, including depression.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428171\" data-linked=\"VistaGen up 5% on preclinical AV-101 data\" data-tweet=\"$VTGN - VistaGen up 5% on preclinical AV-101 data https://seekingalpha.com/news/3428171-vistagen-up-5-on-preclinical-avminus-101-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3428171-vistagen-up-5-on-preclinical-avminus-101-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428169\" data-ts=\"1548946140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLAB\" target=\"_blank\">SLAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428169-needham-steps-to-silicon-labs-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham steps to Silicon Labs sidelines</a></h4><ul><li>Needham downgrades Silicon Labs (NASDAQ:<a href='https://seekingalpha.com/symbol/SLAB' title='Silicon Laboratories, Inc.'>SLAB</a>) from Buy to Hold citing 8-bit MCU concerns and China market isolation after the <a href=\"https://seekingalpha.com/news/3427698-silicon-labs-minus-13_5-percent-misses-analysts-see-upsides\" target=\"_blank\">earnings report</a>.</li><li>The firm thinks high-valuation names like SLAB are more vulnerable to share declines in uncertain economic climates.</li><li>Needham sees value for shares in the range of $65 to $72 rather than its prior $100 price target.</li><li>SLAB shares are <font color=\"red\">down 1.2%</font> to $75.93.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428169\" data-linked=\"Needham steps to Silicon Labs sidelines\" data-tweet=\"$SLAB - Needham steps to Silicon Labs sidelines https://seekingalpha.com/news/3428169-needham-steps-to-silicon-labs-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3428169-needham-steps-to-silicon-labs-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428168\" data-ts=\"1548946136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YRCW\" target=\"_blank\">YRCW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428168-yrc-worldwideplus-14-after-strong-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YRC Worldwide +14% after strong quarter</a></h4><ul> <li>YRC Worldwide (NASDAQ:<a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a>) is <font color=\"green\">up 14%</font> after cruising right past estimates with its Q4 report.</li> <li>The company says pricing discipline and favorable economic trends worked in its favor during the quarter. Operating revenue growth of 3.2% was largely attributed to the increase in revenue per hundredweight of 6.5% for YRC Freight and 6.8% for Regional Transportation.</li> <li>YRC says its operating ratio for the quarter was 95.2% vs. 98.2% last year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428168\" data-linked=\"YRC Worldwide +14% after strong quarter\" data-tweet=\"$YRCW - YRC Worldwide +14% after strong quarter https://seekingalpha.com/news/3428168-yrc-worldwideplus-14-after-strong-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3428168-yrc-worldwideplus-14-after-strong-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428163\" data-ts=\"1548945479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVEO\" target=\"_blank\">AVEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428163-aveo-oncology-down-46-on-delay-of-fotivda-nda-filing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AVEO Oncology down 46% on delay of Fotivda NDA filing</a></h4><ul><li>AVEO Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a> <font color=\"red\">-45.8%</font>) slumps out of the gate this morning following its <a href=\"https://seekingalpha.com/pr/17397660-aveo-oncology-announces-nda-timing-update\" target=\"_blank\">announcement </a>that it will not file a U.S. marketing application seeking approval for FOTIVDA (tivozanib) for the treatment of adult patients with advanced renal cell carcinoma (kidney cancer) until it has more mature overall survival &#40;OS&#41; data from its Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02627963?lead=aveo&amp;phase=2&amp;rank=1\" target=\"_blank\">TIVO-3</a> study.</li><li>The company made its decision after the FDA recommended not to file the NDA because preliminary OS results \"did not allay its concerns\" about the potential negative effect on OS that was cited in the June 2013 complete response letter &#40;CRL&#41;.</li><li>AVEO plans to present detailed results from TIVO-3 at the ASCO GU Symposium in San Francisco in mid-February.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428163\" data-linked=\"AVEO Oncology down 46% on delay of Fotivda NDA filing\" data-tweet=\"$AVEO - AVEO Oncology down 46% on delay of Fotivda NDA filing https://seekingalpha.com/news/3428163-aveo-oncology-down-46-on-delay-of-fotivda-nda-filing?source=tweet\" data-url=\"https://seekingalpha.com/news/3428163-aveo-oncology-down-46-on-delay-of-fotivda-nda-filing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}